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Abstract
Gold catalysis has emerged over the past decade as an important
methodology in the construction of organic molecules. Cationic gold complexes
are robust, versatile, selective and efficient catalysts that can be used to enhance
the electrophilicity of C-C unsaturated bonds. A current area of investigation is the
use of gold to activate allylic alcohol/ether moieties for intramolecular S N2’
nucleophilic attack to form oxygen heterocycles. We have discovered that sterically
bulky, electron-withdrawing oxygen leaving groups drastically improved reaction
efficiency, and bulky leaving groups in combination with substrate substituents
enhanced diastereomeric ratios in the oxygen heterocycle products. These
reactions proceeded smoothly in the presence of many functional groups to
consistently afford high diastereoselectivity. This methodology was attempted in
the synthesis complex spirocyclic ether structures, and used in progress towards
total synthesis of the natural product (±)-centrolobine.
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1. Introduction
1.1. General Considerations in Gold-Catalysis
The development of homogeneous organometallic catalysis in organic
synthesis has allowed access to more complex structures under mild and efficient
reaction conditions. A famous example was the discovery of palladium-catalyzed
coupling reactions in the mid 1970’s by Richard F. Heck1 and Tsunomu Mizoroki.2
Precious metal catalysts like palladium, ruthenium, rhodium and platinum have
been extensively investigated in synthetic methodology, however the study of gold
catalysis began relatively late in comparison.
A few applications of gold catalysis were described in the 1990’s,3 however
the organometallic “gold rush” occurred in the first decade of the 21st century with
the development of phosphine and carbene ligands to form stable gold catalyst
salts. The introduction of these gold catalysts instigated a marked increase in the
number of publications on the topic of gold catalysis with the greatest number of
publications occurring in the most recent year of 2014 with 1,060 publications
(Figure 1-1).4,5
In comparison to other precious metals catalysts used in organic chemistry,
gold salts are relatively affordable in cost per mole even though elemental gold
metal is one of the most expensive metals (Table 1-1).6,7 There are several factors
that influence the price of catalyst including the complexity of the ligand, the
sensitivity, and the demand.8 Additionally, the impressive reactivity and robustness
of gold catalysts allow for potentially lower catalytic loadings with higher turn-over
numbers without loss of catalytic activity due to oxidation or poisoning.
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Figure 1-1. Number of publications on the topic of gold catalysis from 1980-2015.
Table 1-1. Elemental and cationic salt price/mmol of precious metals as of
September 2014.
Metal

Price/mmol in
US $

Catalyst Form

Price/mmol in
US $

Gold

7.74

AuCl / AuCl3

52.88/57.63

Iridium

3.77

IrCl3

72.55

Osmium

2.32

OsCl3

195.24

Palladium

2.80

PdCl2

9.40

Platinum

8.37

PtCl2 / PtCl4

66.23/63.50

Rhenium

4.52

ReCl3

96.26

Rhodium

4.47

RhCl3

65.71

Ruthenium

0.21

RuCl3

10.25

Silver

0.06

AgCl

4.46

2

Gold exists in several oxidation states, the most prevalent of which are
Au(0), Au(I), and Au(III). Au(I) has been intensively studied in catalysis due to its
low oxidation state and linear coordination geometry.9,10 Au(I) catalysts are stable
in the presence of a large number of functional groups, and have a simple
geometry in ligand design. However, in the absence of stabilizing ligands, Au(I)
under goes a rapid disproportionation reaction into Au(0) and Au(III). 11 Many
commercially available water- and air-stable gold complexes have been
synthesized to overcome the limitations associated with this reactivity as shown in
Figure 1-2.4

Figure 1-2. Commercially available Au(I) catalysts.
Though these ligands significantly reduce the disproportionation reaction of
Au(I), this side reaction has been observed despite the presence of stabilizing
ligands. Vyvyan and co-workers observed the disproportionation of 1-2 in a Claisen
rearrangement of allyl aryl ethers.12 The synthetic community has assumed this
disproportionation leads to decreased catalytic activity and increased side
reactions as Au(0) precipitates out of solution, and Au(III) is considered less stable

3

to functional groups in catalysis. 13 , 14 , 15 Contrary to this belief, Au(III) was the
catalytically active species in the reported Claisen rearrangement.
Gold(III) cationic complexes have been poorly investigated, largely because
the scientific community has been focused on reaction methodologies involving
Au(I) cationic complexes due to the simplicity of ligand design for these linear
bicoordinate complexes, and the mild reaction conditions of this low oxidation state
Lewis acid.15 However, there are some potential advantages to Au(III) complexes.
First, the higher oxidation state of this gold complex makes it more electrophilic
and oxophilic, which could indicate increased reactivity in the activation of πsystems by increasing the delocalization of electrons. Second, the tetracoordinate,
square planar coordination geometry of Au(III) complexes allows for greater ability
to tune cationic complexes through bi- or tri-dentate ligand design, and increased
steric bulk near the reaction center may influence diastereoselective and
enantioselective reactions. The work to be presented in this thesis focuses on the
increased reactivity of Au(III), and commercially available ligands that allow for
stereoselective transformations.
Gold was not considered for investigation in the early days of organometallic
catalysis due to its lack of reactivity in its elemental form. The resistance of metallic
gold to oxidation was believed to correspond to a diminished or absent reactivity
as a cationic catalyst. The conditions needed to oxidize gold support this
hypothesis; an extremely caustic mixture of hydrochloric acid and nitric acid,
known as aqua regia (latin for “regal water”), is required to form cationic gold salts.
The unusual lack of reactivity of gold metal is orthogonal to the surprisingly
4

powerful reactivity of cationic gold in a broad range of organic transformations.
These interesting effects of gold are closely related to relativistic effects. In
computational analysis of the relativistic and non-relativistic 6s orbital radii it was
observed gold exhibits the largest relativistic effects among the elements (Figure
1-3).16

Figure 1-3. The relativistic and non-relativistic 6s orbital radii. (Reprinted from ref.
12)
The relativistic effects observed in gold provide a theoretical framework for
rationalizing observed reactivity as well as proposing potential hypothetical
reactivity. The experimentally observed characteristics of cationic gold complexes
may be theoretically described by the contraction of the 6s orbital and expansion
of the 5d orbitals. This relativistic orbital interaction explains the observed yellow
hue of gold metal. The highest occupied molecular orbital (HOMO) and lowest
unoccupied molecular orbital (LUMO) are sufficiently close in energy due to

5

relativistic effects that the highest energy of visible light (blue) will be absorbed to
allow an excitation of an electron from the HOMO to the LUMO, and thereby reflect
all remaining light from the spectrum to give a yellow hue.
Additionally, the atomic radius of gold (144 pm) is significantly decreased
and is comparable to the size of silver (144 pm) (Figure 1-3).17 This relativistic
contraction results in tighter binding energy of the s electrons. This makes the
cohesive metallic bonds much more difficult to oxidize, and gold cationic species
exceptional Lewis acids.

Figure 1-3. Relativistic effects in gold.

1.2. Gold-Catalyzed Addition to π-Systems

Gold(I) and gold(III) species are both Lewis acids with an affinity for π-bonds,
and have the ability to activate soft electrophiles such as C-C double and triple
bonds. The strong Lewis acidity of gold is due to the relative low energy of the
lowest unoccupied molecular orbital (LUMO). This makes cationic gold species

6

ideal catalysts for the mild activation of π-systems. Additionally, since they are
Lewis acids, these catalysts have access to a large selection of commercial
available ligands through coordination of Lewis bases observed in phosphorous
and nitrogen ligands which may be used to tune the electronic and steric
environment of the coordination sphere. Finally, cationic gold delocalizes electrons,
and stabilizes electrophiles through the strong back-bonding character of this atom.
The relativistic expansion of the 5d orbitals in gold increases the back bonding
effect and therefore facilitates electron delocalization.5

1. 3. Gold-Catalyzed Activation of Alkynes
The first and most widely investigated methodology concerning gold
catalysis has been the activation of alkynes. Gold cationic complexes behave as
chemoselective π-acids to remove electron density and promote electrophilic
character, which can then be attacked by a nucleophile.
This synthetic methodology has been utilized in many examples for the mild
activation of alkynes with cationic gold species. In 2004, Arcadi and co-workers
used a cationic gold complex to activate an alkyne for intramolecular nucleophile
attack on aniline 1-5 to form indole 1-6 in high yield and efficient reaction time
(Scheme 1-1).18 An excellent example of the robustness and reactivity of gold
catalyst was the intermolecular addition to an alkyne reported by Nolan and coworkers in which they were able to use 0.01 mol% of catalyst in the hydration of
alkyne 1-7 to obtain ketone 1-8 in high yield using water as a co-solvent and
nucleophile. 19 Additionally, cationic gold complexes may be utilized in mild
7

activation of otherwise unreactive π-systems. Hashmi investigated the synthesis
of hydroxyl-substituted isoindolines from a furan catalyzed by Au(III) chloride in a
Diels-Alder reaction.20 In this reaction the cationic gold species first activates the
terminal alkyne of 1-9 for intramolecular Diels-Alder reaction with the relatively
unreactive furan diene.21 The oxophilic Au(III) chloride mediates scission of the
oxygen bridge, and the restoration of aromaticity to afford isoindoline 1-12 in 97%
yield.

Scheme 1-1. Selected examples of gold-catalyzed activation of alkynes.

8

Trost and co-workers utilized an intramolecular gold-catalyzed alkoxylation
of an alkyne to form a tetrahydropyran in a late stage in the total synthesis of the
complex natural product, Bryostatin 16 (Equation 1-1). This is an excellent use of
Au(I) in the activation of an alkyne to afford the corresponding tetrahydropyran in
73% yield without side reactions or decreased reactivity in the presence of many
other functional groups including acetal, conjugated systems and an unprotected
alcohol.22

(1-1)

1.4. Gold-Catalyzed Activation of Allenes
The ability to activate alkynes with cationic gold species has attracted the
interest of many other groups towards the activation of other reactive π-bonds like
allenes. In 2006, Widenhoefer and co-workers investigated the gold catalyzed
cyclization of allene 1-15 to form tetrahydropyran 1-16 in high yield and moderate
diastereomeric ratios (Scheme 1-2). 23 Shortly after, in 2008, Widenhoefer
observed the intermolecular hydroamination of allene 1-18 in good yield at room
9

temperature.24 In 2007, an electrophilic aromatic substitution was used by Ohno
and co-workers to synthesize dihydroquinoline 1-21 from allenic aniline 1-20 in
92% yield in 5 minutes at room temperature.25

Scheme 1-2. Selected examples of gold catalyzed activation of allenes.

The advantage of utilizing allenes as electrophiles in synthesis is the ability
to form a stereogenic center by stereoselective activation.26 Chiral bisphopshine
ligands26 and phosphate counterions27 have attracted significant interest for their
ability to be synthesized from readily available sterically bulky, axially chiral
binapthalene derivatives. These privileged chiral resolving agents have been
investigated thoroughly by several groups in enantioselective gold catalyzed
reactions, and have proven to be efficient stereoselective ligands in synthesis.28
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Toste has published many examples of enantioselective gold-catalyzed
reactions. In 2007, his group used a chiral phosphine ligand-based gold catalyst in
the enantioselective intramolecular hydroamination of allenes in which they were
able to obtain pyrolidine 1-23 in quantitative yield and 99% enantiomeric excess
(Scheme 1-3).

29

Due to the linear bi-coordinate geometry of Au(I), low

enantioselectivity is often observed because the steric bulk of the ligand is located
relatively far from the reaction center.18
Toste and co-workers hypothesized that chiral information may be moved
closer to the reaction center by utilizing a chiral anion to associate near the
electrophilic cation formed when the gold complex activates the substrate for
nucleophilic attack. This group observed exceptional enantioselectivity in the Au(I)
catalyzed hydroalkoxylation of allene 1-25 when they used chiral counter ion silver
salt 1-27 in a non-polar solvent.30
Though gold-catalyzed reactions have seen significant success in the
activation of alkynes and allenes, this methodology is limited in the activation of
alkenes. Several examples have been reported in literature, but unlike other
palladium and platinum activation of alkenes, gold has required increased
temperatures to promote electrophilic activation. He and co-workers found 85 °C
was required to perform the gold-catalyzed addition of phenol to an alkene in 84%
yield in 15 hours (Equation 1-2).31

11

Scheme 1-3. Selected examples of enantioselective addition on allenes.

(1-2)
1.4. Metal-Catalyzed Activation of Unsaturated Alcohols
Unsaturated alcohols are ubiquitous, readily synthesized intermediates in
organic chemistry. Transformations involving these functional groups under
Brønsted or Lewis acidic conditions have been extensively investigated. Metal
catalyzed activation of allylic, propargylic and benzylic alcohols have broad utility
in organic synthesis and many reports have general applicability towards the use
in gold catalysis.32-42
Allylic alcohols or ethers can be synthesized by reduction of propargylic
alcohols, reduction of α,β-unsaturated carbonyls, or olefin metathesis with allylic
12

alcohols or ethers. These allylic alcohol moieties can act as surrogates for allenes
with similar reactivity, greater stability and simple preparation. Metal activation of
allylic acohols has been investigated, but the catalytic loadings remain relatively
high in comparison to alkynes and allenes, and require higher temperatures or
longer reaction times.
Several examples in the literature suggest the potential for these functional
groups to allow for electrophilic activation with Lewis acid catalysis.32-42 Uenishi
and co-workers demonstrated a highly efficient Pd(II)-catalyzed intramolecular
cyclization for the formation – from chiral allylic alcohols – to afford
tetrahydropyrans like 1-32 containing tetrasubstituted stereocenters. This reaction
proceeded stereospecifically by 1,3-chirality transfer through a syn-SN2 process to
afford 2,2,6-trisubstituted tetrahydropyrans and spirohydropyrans in high yields
(Scheme 1-4). 32 However, excessively high catalytic loading (30 mol %) was
required for this reaction. Ruthenium(I)-catalyzed intermolecular Friedel-Crafts
reactions have been reported by Wörle and co-workers which afforded 3substituted indoles 1-35 in quantitative yields.33 This reaction required the use of
camphorsulfonic acid as a co-catalyst. Mashima and co-workers used 1 mol % of
a platinum(II) catalyst in the activation of allylic alcohol 1-37 for addition of aniline
1-36. Though the catalyst loading was low (1 mol%), the reaction required high
temperatures in order to achieve good yield (86%) of 1-38.34

13

Scheme 1-4. Selected examples of metal catalyzed activation of allylic alcohols.

Propargyl alcohols are versatile and useful intermediates in organic
synthesis. Activation of these electrophiles with an alcohol leaving group allows for
powerful transformations allowing access to numerous types of functional groups
by altering reaction conditions. 35 Due to their increased electron density these
functional groups have been utilized in complex cascade reactions, and multi-step,
one-pot procedures. Propargylic alcohols activated by metal salts are often used
to form 5-membered heterocycles.36 In 2009, Aponick and co-workers developed
a synthesis of furans, pyrroles and thiophenes by gold-catalyzed activation of
propargyl alcohols.37 An excellent example from this work demonstrated the use
of as little as 0.05 mol% of catalyst to convert a propargyl alcohol 1-39 into furan
1-40 in 92% yield in only 15 minutes (Scheme 1-5). An interesting intermolecular
reaction to form furan 1-43 in modest yield from readily available aryl boronic acid
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1-41, propargyl alcohol 1-42 and carbon monoxide under low rhodium(I) catalyst
loading was reported in 2010 by Castanet and co-workers.38

Scheme 1-5. Selected examples of metal catalyzed activation of propargylic
alcohols.

Aponick and co-workers have recently reported on gold-catalyzed reactions
of propargyl alcohols to form complex heterocyclic structures. This group
developed a novel approach to unsaturated spiroketal structures that addresses
the regioselectivity issues commonly reported in metal-catalyzed spiroketalization
of alkynes. 39 The reaction sequence is regulated by the use of an acetonide
protecting group in 1-44, which in the process of the reaction undergoes extrusion
of acetone to deliver a broad range of spiroketals like 1-44 in good yields and
diastereoselectivities (Scheme 1-6). Aponick’s group has also described the
synthesis of cyclic 2-oxodienes from propargyl alcohols, which can be used in a
subsequent Diels-Alder reaction.40 The dehydrative cyclization reaction proceeds
smoothly with 5 mol % catalyst in 5 minutes. The subsequent diene readily

15

underwent a cycloaddition in-situ with a variety of dienophiles. This method
allowed for a new strategy to synthesize indolocarbazole alkaloids.

Scheme 1-6. Complex structures formed by Au(I) catalyzed activation of propargyl
alcohols.

Ionization of benzylic alcohols under mild acidic conditions has also been
extensively investigated. The resonance-stabilized cation formed after the loss of
water may be reacted with any nucleophile, usually through an SN1 mechanism.
This allows access to many carbon-carbon and carbon-heteroatom bonds. In 2006,
Campagne and co-workers utilized this reactivity by activation of benzylic alcohols
with 5 mol % of various Lewis acids in the nucleophilic substitution with tosylamine
(Scheme 1-7).41 Of all the Lewis acids tested, Au(III) cationic salt proved to be the
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best catalyst, and the use of organic acids gave poor yields and side products.
This type of transformation has also been used in Michael style addition with βketoesters. 42 This reaction worked well in the presence of various Lewis acids
though the catalyst loading was high.

Scheme 1-7. Selected examples of Lewis acid activation of benzylic alcohols.

The facile synthesis, and Lewis acid activation under mild conditions of
unsaturated alcohols makes these intermediates attractive substrates for
investigation. Allylic alcohols, however, are less reactive and more difficult to
activate under mild conditions but are much more accessible and versatile
intermediates in organic synthesis. Cationic gold complexes have shown
promising reactivity in this field, and activation of these systems for intramolecular
cyclization is an attractive area for investigation of new methodology.
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2. Metal-Catalyzed Cyclizations to Form Saturated Oxygen Heterocycles
2.1. Saturated Oxygen Heterocycles in Natural Products
Saturated oxygen heterocycles are ubiquitous structural motifs in
biologically active natural products. The prevalence of these functional groups in
synthetic targets with potent biological activities make them important structural
components that have attracted the interest of the synthetic community.43

Figure 2-1. Selected examples of natural products containing saturated oxygen
heterocycles.
There are several natural products with complex saturated oxygen
heterocycle structural motifs with excellent biological activity. Spirastrellolide A 2-
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1, extracted from marine sponge Spirastrella coccine, is potent inhibitor of protein
phosphatase 2. 44 This compound has spiroketal and bis-spiroketal structural
features which are difficult functional groups to synthesize, but are essential for the
activity of the molecule. Bryostatins are a group of macrolactones isolated from
Bugula neritina, a species of bryozoan.45 These architecturally complex organic
structures are potent modulators of protein kinase C, and have demonstrated
promising activities against cancer, HIV and Alzheimers.46 An important feature of
this molecule is the joined tetrahydropyran rings which form the structural manifold
of this compound. Sorangicin A contains a characteristic dioxabicyclo[3.2.1]octane
skeleton functionality.47 This macrolide was isolated from myxobacteria Sorangium
cellulosum and has demonstrated remarkable antibiotic activity against of broad
spectrum of gram-positive and gram-negative bacteria, as well in the treatment of
solid tumors resistant to alternative treatments (i.e., Taxol).48 Brevetoxins are a
class of marine ladder toxins produced by Karenia brevis, a marine dinoflagellate
found in the Gulf of Mexico, known to be responsible for oceanic red tide.49 These
compounds bind to the voltage-gated sodium channels in nerve cells and disrupt
the central nervous system. The complex cyclic polyether structure is exceedingly
difficult to synthesize due to the ten fused oxygen heterocycles. Traditional
approaches to the synthesis of cyclic ethers are efficient, but are limited in the
application to complex chiral structures.50 Metal based catalysis has proven to be
a powerful synthetic tool to achieve high yield and stereoselectivity through the use
of stable ligated complexes.
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2.2. Transition Metal-Catalyzed Activation of Alkenes
The synthetic community has long recognized the power of metal-catalyzed
intramolecular reactions and continues to expand the scope of these
methodologies towards the synthesis of saturated oxygen heterocycles.

51

Contemporary approaches utilize cationic metals as catalysts in the intramolecular
hydroalkoxylation of unactivated alkenes. Alkenols are readily available, stable
synthetic intermediates. Coordination of a metal activates the double bond by
formation of π-complex for nucleophilic addition by an alcohol followed by
protodemetallation (Scheme 2-1).

Scheme 2-1. General reaction mechanism of metal-catalyzed cyclization of
alkenol.

In 2004, Widenhoefer and co-workers utilized only 0.5 mol % of platinum
catalyst in the cyclization of alkenol 2-9 to form a tetrahydropyran 2-10 with
excellent diastereoselectivity (Scheme 2-2). Though this transformation tolerates
a large variety of functional groups like pivaloate and acetate esters, amides, silyl
and benzyl ethers, only moderate yields were reported and high temperatures
were required.52 This reaction was also investigated by He and co-workers using
triphenylphosphine silver(I) triflate as a catalyst to obtain the tetrahydropyran 2-12
in 15 minutes at reflux in dichlorethane.53
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Lanthanides have promising activity that has been investigated in this
methodology, but lanthanide salt-catalyzed processes usually requires toxic,
highly polar, moderately coordinating solvents.54 Marks and co-workers were able
to utilize an non-volatile environmentally benign imdizolium-based ionic liquid in
the hydroalkoxylation using ytterbium(III) triflate to form a benzofuran 2-14. 55
Cationic metal activation of olefins is a practical and efficient methodology in the
synthesis of cyclic ethers, however harsh conditions including high temperatures
and long reaction times are often required.

Scheme 2-2. Metal-catalyzed hydroalkoxylation/cyclization of unactivated alkenes.

2.3. Transition Metal-Catalyzed Activation of Allylic Alcohols
Activation of allylic alcohols for inter- and intramolecular substitution reactions has
been investigated with many different metal-based catalysts. Several mechanisms
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have been suggested for this type of reaction, which differ based on the metal
employed in the activation of the allylic alcohol. A syn SN2’ process has been
reported with Pd(II)56 (Scheme 2-3, A), a π-allyl metal complex formation with
Pd(0),57 Pt(0),58 Rh(I)59 or Ru(II)60 (Scheme 2-3, B), and stabilized allyl cation with
Fe(III)61 or Bi(III)62 (Scheme 2-3, C).

Scheme 2-3. Mechanistic pathways in the metal-catalyzed activation of allylic
alcohols: A) syn SN2’, B) π-allyl metal complex, C) stabilized allyl cation.

In 2010, Cossy and co-workers investigated the iron(III) catalyzed activation
of a mono-allylic diol 2-15 to form an allyl cation intermediate which intramolecular
nucleophilic addition allow access to 2,6-disubstituted tetrahydropyrans 2-16 in
good yield and moderate diastereostereomeric ratios (Scheme 2-4).61 Uenishi and
co-workers used a palladium(II) catalyst to perform a syn SN2’ cyclization upon the
allylic alcohol to form a tetrahydropyran 2-18 in 93% yield as a single
diastereomer.56 Kitamura and co-workers reported the ruthenium(II) catalyzed
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enantioselective cyclization of mono-allylic diol 2-19 to form tetrahydropyran 2-20
in 90% yield and 93% ee by utilizing a new chiral ligand 2-21 they developed.60
Scheme 2-4. Selected examples of metal-catalyzed cyclization of allylic alcohols.

2.4. Gold-Catalyzed Activation of Allylic Alcohols
Prior to 2006, gold was poorly investigated in the activation of allylic
alcohols, however there are several reports which suggest Au(I) or Au(III) could
be exceptionally active catalysts in this methodology.1,63 When Au(III) is used to
activate the allylic alcohol, evidence suggests a allyl stabilized cation is formed
which may undergo regioisomerization. In 2009, Chan and co-workers
investigated the Au(III)-catalyzed activation of cinnamyl alcohol 2-22 in an SN1
nucleophilic substitution with 1,3-diketone 2-21 to afford 2-23 in good yield
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(Scheme 2-5).64 This same group also described the Au(III)-catalyzed activation
of phenyl substituted allylic alcohols for electrophilic aromatic substitution with
arenes and heteroaromatics like 2-26 in good yields.65 Liu and co-workers have
reported work involving the formation in carbon-heteratom bonds in which they
described the Au(III)-catalyzed amination of allylic alcohols like 2-28 in good
yield.66

Scheme 2-5. Selected examples of Au(III) catalyzed activation of allylic alcohols.

These examples represent the reactivity of cationic gold to activate allylic
alcohols for intermolecular substitution. This methodology has also been applied
in intramolecular reactions. Previous work completed in the Vyvyan group
involved the investigation of Au(I)-catalyzed Claisen rearrangement of allyl aryl
ethers. In this investigation they reported cationic Au(I) and Au(III) catalyzed the
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reaction of several aryl allyl ethers. However, due to a competing cationic
pathway Au(I) complexes catalyzed [3,3] and [1,3]-rearrangement products in
substrates like 2-29 through an ionic mechanism rather than a concerted
pathway to afford products 2-30, 2-31, and 2-32.67
Contrary to previously reported information this group discovered
homogenous Au(III) was an exceptionally active catalyst that preferentially
favored the intended product 2-30 by progressing through the hypothesized
concerted [3,3]-rearangment mechanism (Scheme 2-6). Encouraged by these
results previous group members sought to investigate this reaction further with
napthol derivatives. Utilizing 10 mol % of Au(OTf)3 formed in situ, they were able
to produce the single intended rearrangement product in 89% at 0˚C in 6.25
hours.68 Though the catalyst loading was relatively high, this experiment
illustrates the potential for homogenous Au(III) complexes to allow for increased
reactivity while maintaining selectivity in the activation of allylic alcohols.
Furthermore, researchers were also able to selectively form a cyclized product 234 in 66 % yield when using 10 mol % PPh3PAuOTf.68 Additionally, a researcher
in this group, Dimmit, found that the same gold catalyst could facilitate the
formation of a lactone 2-36 from the cyclization of a carboxylic acid-containing
allylic ether substrate 2-35.12
These experiments stimulated our interest to utilize the activation of allylic
alcohols towards the formation of cyclic ethers and lactones. Our initial
hypothesis was as follows: homogenous Au(III) may allow for increased and
ligand-diversified reactivity over other metal based methodologies involving the
25

catalytic activation of allylic alcohols towards the intramolecular formation of
saturated oxygen heterocycles and lactones.

Scheme 2-6. Selected examples Au(I) and Au(III) catalyzed activation of allylic
alcohols for Claisen rearrangement.
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3. Synthesis of Lactones
3.1. Lactones in Natural Products
Lactones are abundant structural motifs observed in natural products. The
flowering plant genus Goniothalamus has been a resource for several cytoxic
acetogenins and styryl-lactones such as cardiopetalolactone 3-1, goniofufurone 32, and annonacin 3-3; all of which incorporate lactones in their molecular
architectures (Figure 3-1). 69 Therefore, facile methodologies to give access to
these structural features would have broad utility in medicinal chemistry and
natural product synthesis.70

Figure 3-1. Selected examples of lactone containing natural products.
Cationic gold complexes have been utilized in the catalytic cyclization to
synthesize lactones by activation of unsaturated carbon systems. In 2006, Pale
and co-workers utilized the strong Lewis acidity of Au(I) to activate alkyne 3-4 for
intramolecular alkoxylation with a carboxylic acid. This reaction allowed access to
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a myriad of substituted enol lactones like 3-5 in high yield (Scheme 3-1).71 This
reactivity has also been employed with allylic alcohols. Bandini and co-workers
utilized Au(I) complexes in the synthesis of functionalized -vinylbutryolactones
like 3-7 by intramolecular oxaallylic alkylation with primary alcohols like 3-6. This
group reported good yields obtained for a range of malonyl and acetate
derivatives.72

Scheme 3-1. Selected examples of Au(I) catalyzed cyclization to form lactones.

In both examples, lactone formation was achieved efficiently with
inexpensive readily available synthetic intermediates, and mild reaction conditions.
However, like most gold-catalyzed reactive methodologies, lactone formation has
primarily focused on Au(I) catalyst systems. Furthermore, electrophilic activation
of carbon atoms has focused on Au(I) complexation directly with  bonds. As
previously reported Au(III) is an exceptional catalyst to activate allylic ethers and
alcohols by complexation with the allylic oxygen and the  bonds to delocalize
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electrons for nucleophilic attack, and has been relatively unexplored in this
application.
3.2. Gold(III)-Catalyzed Cyclization to Form -Butyrolactones
To test the hypothesis that allylic alcohols and ethers may be activated
under mild conditions with Au(III) species to form -butryolactones we synthesized
a substrate for investigation by olefin-metathesis with ethyl pent-4-enoate 3-8 and
diol 3-9 using Grubbs 2nd generation catalyst (Equation 3-1).

(3-1)
Early in our work we had difficulty obtaining the desired cross-metathesis
product in good yield and purity due to an unintended olefin isomerization to
produce a complex mixture containing aldehyde 3-11. This undesirable olefin
isomerization is a known problem in cross-metathesis. Although the mechanism is
not completely understood it is believed to proceed through a -hydride elimination
(Scheme 3-1).73
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Scheme 3-1. Suggested mechanism of undesired ruthenium catalyzed
isomerization.

Grubbs and co-workers have reported the phenomenon of undesirable
isomerization during olefin metathesis, and have also investigated the effect of
additives on the prevention of this side reaction. Of the additives they tested, pbenzoquinone was found to prevent olefin isomerization of a number of allylic
ethers and long-chain aliphatic alkenes during olefin metathesis reactions with a
ruthenium-based catalysts.73 We utilized this mild, inexpensive, and effective
additive to inhibit the formation of the aldehyde and improve product yield and
purity in olefin-metathesis.
We attempted the cyclization of 3-10 with 10 mol % of catalyst systems
AuCl3 / 3 AgOTf and Ph3PAuCl / AgOTf. Deuterated chloroform was used as a
solvent to enable observation of reaction progress by 1H NMR. After 24 hours, the
reaction had not progressed in either catalyst systems at room temperature
(Equation 3-2). This result did not improve even with longer reaction times. In an
effort to keep the reaction conditions mild, we first sought to optimize the substrate
rather than increase the temperature or investigate the effects of additives in the
reaction.
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(3-2)
Toward improving the reactivity of our substrate, we hypothesized a
mechanism for the reaction based on previously reports of homogenous cationic
gold catalysis. Due to the oxophilicity of Au(III), we believed it would coordinate to
the allylic alcohol oxygen and polarize the electrons of the -bond activating the
system for nucleophilic attack (Scheme 3-2). Therefore, if we were to install an
electron withdrawing allylic ether it would increase the reactivity of the allylic ether
system toward nucleophilic attack in the presence of Au(III). Additionally, we
hypothesized that installation of an electron donating substituent for the ester could
increase electron density on the carbonyl oxygen, which would increase the
nucleophilicity of this atom in the reaction. To test this hypothesis we envisioned
several electron withdrawing substituents we could install to form an allylic ether,
and several electron donating substituents to install to form the ester.

Scheme 3-2. Purported mechanism Au(III) catalyzed activation of allylic ethers to
form -butyrolactones.

We synthesized a t-butyl ester substrate by reaction of t-butyl alcohol 3-14
with acid chloride 3-13 to form ester 3-15 (Scheme 3-3). The poor yield observed
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in this esterification was a result of water in the t-butyl alcohol and the elimination
reaction to form isobutene. Olefin metathesis with diol 3-2 afforded substrate 3-16,
which upon reaction with the gold catalyst systems again afforded less than 10%
of product as determined by 1H NMR analysis. The isolated yields were not able
to be determined due to the high volatility of the product. Therefore, all reported
yields are relative conversion determined by 1H NMR analysis. Though this yield
is low, we were encouraged that some product was formed.
We then hypothesized that the electron donating benzyl ester group with
the ability to from a stable tropylium cation would be an exceptional electron
donating substituent in this methodology. In order to synthesize intermediate 3-11
we utilized a Dean-Stark apparatus to shift the equilibrium to form the esterified
products by extracting water from the reaction. This improved the esterification
yield from the previously used procedure in the synthesis of the t-butyl ester 3-7.
Cross metathesis with diol 3-2 afforded substrate 3-12 for gold cyclization.
Unfortunately, this substrate also performed poorly in the cyclization to form
lactone 3-8, again forming less than 10% products after 24 hours for both gold
catalyst systems (Scheme 3-4).
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Scheme 3-3. Synthesis and gold catalyzed cyclization of 3-16.Error! Bookmark
ot defined.

Scheme 3-4. Synthesis and gold catalyzed cyclization of 3-20.

Undeterred, we sought to optimize the allylic oxygen leaving group
hypothesizing that the reaction efficiency would improve with an electron
withdrawing leaving group. In order to optimize the allylic oxygen leaving group we
choose an acetate group which could be easily and selectively installed on a
primary alcohol. The facile installation of this functional group on substrates 3-10,
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3-16, and 3-20 afforded the intended products in high yield and purity (Scheme 35).

Scheme 3-5. Synthesis of substrates 3-21, 3-22, and 3-24.Error! Bookmark not
efined.

To our delight when these substrates were subjected to a Au(III) catalyst
substrates 3-22 and 3-23 afforded the lactone product in good yield in 48 hours at
room temperature (Scheme 3-6). Au(I) was not reactive in this transformation
supporting our hypothesis regarding the increased Lewis acidity of Au(III) in
combination with the substrate optimization was essential for promoting the
reactivity. Based on this result we sought to further investigate Au(III) as an active
catalyst and to further optimize our substrate with more powerful electron
withdrawing groups.
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Scheme 3-6. Gold-catalyzed cyclizations of substrates 3-21, 3-22, and 3-23.

Aryl allyl ethers have previously been reported by our group to promote the
gold-catalyzed lactonization with carboxylic acids.12 Therefore, phenol based
compounds offered an interesting opportunity to tune the reactivity of our allylic
ether leaving group by utilizing the electronic effect of substituents on the aromatic
ring. These phenolic structures may be installed by an efficient and simple method
known as the Mitsunobu etherification.12 Furthermore, investigation of these
sterically bulky leaving groups could provide useful insight for the investigation into
diastereoselective

and

enantioselective

synthesis

of

saturated

oxygen

heterocycles.
There were two important considerations in the design of these substituted
phenol based leaving groups. Substituents that perturbed the electronics through
resonance would have the greatest effect on the allylic ether oxygen, therefore
electron withdrawing substituents were installed in the ortho and para positions.
As previously reported aryl allyl ethers are reactive at the ortho position in Claisen
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rearrangement reactions. 12, 67 Therefore, these aryl leaving groups must always
be substituted at the ortho positions to prevent this side reaction. We envisioned
leaving groups to test as seen in 3-24, and 3-25 (Figure 3-1).

Figure 3-1. Selected phenol leaving groups for allyl etherification.

These leaving groups were installed on the most effective ester substrate
3-20 with the benzyl ester in good yields by Mitsunobu etherification using
diisopropyl azodicarboxylate (DIAD) and triphenylphospine (Scheme 3-7), and
then tested in Au(III)-catalyzed cyclization (Scheme 3-8).

Scheme 3-7. Mitsunobu etherification to synthesize substrates 3-26, and 3-27.

As predicted, the reactivity in Au(III)-catalyzed cyclization increased as the
electron withdrawing nature of the allylic ether leaving group increased, with the
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best yield of the substrate with the 3-26 leaving group. This leaving group
introduces the facility to install an electron withdrawing allylic ether leaving group
for less reactive -systems in gold catalysis. Additionally it was hypothesized that
the steric bulk of this leaving group could be used in the stereoselective
cyclizations to from cyclic ethers.

Scheme 3-8. Gold(III)-catalyzed lactonization of allyl aryl ethers.

Reactions conducted 0.25M in CDCl3 utilizing 10 mol% AuCl3 / 3 AgOTf as a
catalyst with basic alumina added as desiccant. Yield determined by NMR.Error!
ookmark not defined.
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4. Synthesis of Saturated Oxygen Hetereocycles
4.1. Diastereoselective Synthesis of Saturated Oxygen Heterocycles
4.1.1. Gold-Catalyzed Cyclizations of Mono-Allylic Diols
In 2008, Aponick and co-workers reported the Au(I)-catalyzed cyclizations
of mono-allylic diols to form the 6-membered oxygen heterocycles known as
tetrahydropyrans. Several sources of cationic gold were investigated as shown in
Scheme 4-1.74 AuCl3 and Ph3PAuCl / AgOTf worked the best in this
transformation giving tetrahydropyran 4-2 in excellent yields and short reaction
times. This group chose not to investigate the Au(III) catalyst due to the
assumption that oxophilicity of this species could hinder this catalyst in the
presence of functional groups. They were also able to show that the
homogenous Au(I) species is the active catalyst as Ph3PAuCl, AgOTf and triflic
acid were poor Lewis acids for the transformation. An initial mechanistic
investigation demonstrated that the reaction likely undergoes a SN2’ mechanism
rather than an allyl cation intermediate as demonstrated by the complete
conversion of mono-allylic diol 4-3 to tetrahydropyran 4-4 in just 15 minutes,
whereas substrate 4-5 failed to react in extended reaction times and higher
temperatures.
According to the authors, AuCl3 did not proceed through the allyl cation
mechanism in this experiment either. To confirm this result was also true for
homogenous Au(III), a simple experiment was devised with allylic alcohol 4-6 in
which 5 mol % of Au(OTf)3 formed in situ was monitored by 1H NMR analysis at
room temperature for 24 hours then in refluxed CDCl3 for 24 h (Equation 4-1).
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Dihydrofuran product 4-7 was not observed, supporting the hypothesis that
Au(III) does not promote through an allyl cation intermediate.

Scheme 4-1. Investigation of Au(I) and Au(III) in catalytic cyclization of monoallylic diols.

(4-1)

4.1.2. Gold(I)-Catalyzed Diastereoselective Synthesis of 2,6-disubstituted
THPs and 2,5-disubstituted THF
Aponick and co-workers investigated the diastereoselective synthesis of
2,6-disubstituted

tetrahydropyrans

and
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2,5-disubstituted

tetrahydrofurans

(Scheme 4-2).74 Compounds 4-10 to 4-14 were successfully synthesized in high
yield with moderate to high diastereomeric ratios by reducing the reaction
temperature to -50°C or -78°C.

Scheme 4-2. Diastereoselective synthesis of 2,6-disubstituted THPs and THF.

We hypothesized that the allylic ether leaving group 3-26 introduced in
chapter 3 would improve the diastereoselectivity in the Au(III)-catalyzed cyclization
of cyclic ethers across a broad scope of substrates at room temperature.
This is because the electron withdrawing, sterically bulky leaving group
would activate the reaction by promoting electron delocalization in the presence of
Au(III) as previously reported, while the steric bulk would create a large energy
difference between the transition state of the cis-equatorial diastereomer and
trans-diastereomer. This is due to the concerted SN2’ mechanism which means
the sterically bulky allylic oxygen leaving group is still present in the transition state.
In the tetrahydropyran transition state the substituents may occupy the axial or
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equatorial position. If both substituents occupy the equatorial position they avoid
the steric bulk of the 1,3-diaxial interactions in the ring, and the 6-membered cyclic
ether will assume a relatively low energy chair-conformation 4-16. However, if a
substituent occupies the axial position it encounters the 1,3 diaxial intereactions of
the tetrahydropyran ring, and assembles into the higher energy twist-boat
conformation 4-17. The difference in energy between a substituent occupying the
equatorial position over the axial position is referred to as the A-value. 75 The
relative

energy

difference

between

the

transition

states

governs

the

diastereoselectivity of the reaction, therefore using substituents with relatively
large A-values in combination with sterically bulky allylic oxygen leaving groups
should create a greater energy difference between the transition states to
preferentially form the cis-diastereomer.76

Scheme 4-3. Representation of transition states in the substrate dictated
diastereoselective formation of tetrahydropyrans.
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4.2. Synthesis of Substrates for Gold(III)-Catalyzed Cycloetherfication
Substrates for Au(III)-catalyzed cyclization to form saturated oxygen
heterocycles were prepared by nucleophilic addition to aldehydes with various
Grignard reagents, followed by olefin cross-metathesis, and Mitsunobu
etherification (Scheme 4-4).

Scheme 4-4. General synthesis of substrates for gold-catalyzed formation of cyclic
ethers.
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Table 4-1. Isolated yields from preparation of functionalized mono-allylic diols.

aYields

reported in reference Error! Bookmark not defined. bProduct lost due to

quipment malfunction. cReaction formed a complex mixture, no product was
isolated.

The olefin-metathesis step to form 4-21a-j sometimes gave poor yields and
low product purity due to the previously reported undesirable olefin isomerization. 73
Additionally, in order to obtain higher yields it was necessary to use greater than 6
equivalents of the diol 3-2 because both alkenes of the reaction are considered
type I, fast homodimerization species in the presence of Grubbs 2nd generation
catalyst.77 In order to obtain high yields with two fast homodimerization species,
one of the species must be used in excess in order to achieve the statistical
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outcome of equilibrium. Additionally, the intended products were often difficult to
separate from the excess reagent.
Instead, we sought to improve upon reaction by using a protected allylic
alcohol which would be a type II, slow homodimerization species.77 This would only
require two equivalents of the reagent for good yields, and prevent the
isomerization of the allylic alcohol to the aldehyde. We used cis-1,4-diacetoxy,-2butene (4-23), which allowed access to the protected diol, and an additional
substrate 4-24 for gold-catalyzed cyclization with a leaving group previously shown
to be sufficiently electron withdrawing to activate the allylic oxygen moiety.
Furthermore, this acetate protecting group was easily removed in an hour in near
quantitative yield to afford 4-21a (Scheme 4-5).

Scheme 4-5. Synthesis of intermediates 4-24 and 4-21a.

In order for the Mitsunobu etherification step to be chemoselective for the
primary alcohol, the reaction was cooled to -20 ˚C. The secondary alcohol is more
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sterically hindered and therefore requires a higher activation energy than the
primary alcohol. Chemoselectivity was generally good in this reaction with
sufficient yields of the intended product, and was considered more efficient than
using of a protecting group on the secondary alcohol.
A symmetrical substrate was also synthesized with intention to not only
investigate diastereoselectivity, but the utility for Au(III) to be used in
enantioselective reactions. To prepare this substrate a nucleophilic addition was
performed on ethyl formate with a Grignard reagent prepared from 5bromopentene. This intermediate was reacted in olefin metathesis with 4-23 to
afford substrate 4-28 (Scheme 4-6). The acetate was removed to afford 4-29, and
3-26 was installed by Mitsunobu etherification to yield 4-28.

Scheme 4-6. Synthesis of substrates 4-26, 4-27 and 4-28.
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4.3. Substrate Scope of the Diastereoselective Formation of Cyclic Ethers
A broad range of substrates were synthesized using the described methods
to investigate the reaction scope of the Au(III)-catalyzed formation of cyclic ethers
(Table 4-2). The experimental set-up for these reactions was designed with the
intent to remove as much experimental variability as possible from analysis of the
scope of this diastereoselective transformation. The reactions were performed
under argon, at room temperature, in a dry culture tube with basic alumina as a
desiccant. Basic alumina was used not only to adsorb any water that could
potentially hinder the reaction, but also to neutralize any acidic protons which could
deprotect the allylic ether leaving group, thereby decreasing diastereoselectivity.
CDCl3 was used as a solvent so the reaction could be monitored by 1H NMR.
To our excitement, these reactions progressed to full conversion within 24
hours with 10 mol % of the Au(III) catalyst system. In support of our hypothesis the
optimized allylic ether leaving group 3-25 increased the diastereoselectivity in this
reaction at room temperature for all substrates, and in the case of forming
tetrahydropyran rings we are not able to observe the minor diastereomer in
determination of the diastereomeric ratio by 1H NMR analysis in entries 3-6 and 10
of Table 4-2. Therefore, we assigned a diastereomeric ratio of 99:1 based on the
sensitivity of the NMR. In comparison, substrates which used an allylic alcohol
leaving group in the formation of tetrahydropyrans (entries 2, 3 and 12 of Table 42) exhibited consistently lower diastereomeric ratios of 4:1.
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Table 4-2. Gold(III)-catalyzed cyclizations to form saturated oxygen
heterocycles.
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Reactions conducted at room temperature for 24 hours, 0.25M in CDCl3 utilizing
10 mol% AuCl3 / 3 AgOTf as a catalyst with basic alumina added as desiccant.
aIsolated

yield. bDiastereomeric ratio determined by NMR. cRelative conversion

determined by NMR. dIsolated yields reported in reference Error! Bookmark not
efined..

In order to assign the configuration of the major diastereomers in the
cyclization experiments, 1H NMR nuclear Overhauser effect spectroscopy
(NOESY) was performed. This type of spectroscopy established correlations
between nuclei which are physically close in proximity to each other in the
molecule regardless of the bonds between them.78 This spectroscopic
experiment takes advantage of the nuclear Overhauser effect (NOE) by which
nearby atoms (within approximately 5 Å) proceed through a cross-relaxation
mechanism related to spin-lattice relaxation. The NOESY experiment was
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performed in a one-dimensional fashion by pre-selecting the individual
resonances of the protons located at the 2 and 6 positions on the
tetrahydropyran ring. Irradiation of the frequency of one resonance results in a
strong negative signal, while neighboring nuclei are identified by weaker positive
signal as a result of the NOE. In all of the experiments the major diastereomer of
the Au(III)-catalyzed cyclization was the thermodynamically favored syn product
(Figure 4-1).

Figure 4-1. 1H NMR Nuclear Overhauser effect spectra (NOESY) in the
determination of the major and minor diastereomer of 4-28.
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It is important to note that the diastereomeric ratio of the 5 and 7
membered heterocycles which utilized the optimized allylic ether leaving group
were decreased in comparison to the tetrahydropyran substrates. This is largely
due to the energy difference of the conformations of these cyclic structures.
Tetrahydropyran molecules are very similar to cyclohexane adopting a stable
chair conformation with bond angles as close to 109.5˚ as possible, and
positioning sterically bulky substituents in the equatorial positions. The relative
energy difference between the most stable conformations “chair” and “twist-boat”
is 5.5 kcal/mol (Figure 4-1). However, in tetrahydrofuran the 5-membered ring
has some torsional and ring strain. The energy difference between the axial and
equatorial positions of the envelope conformation is significantly diminished and
the ring rapidly interconverts between the two. In an oxepane the relative energy
difference is also lower than in tetrahydropyran, and the ring may adopt many
different lower energy conformations the analysis of which is actually quite
complex. The “twist-chair” is the lowest energy conformation, while the “boat”
forms are only few kilocalories per mole higher in energy.79
Therefore, the allylic ether leaving group we have introduced aids in the
diastereoselective formation of these cyclic ethers. However, in order to improve
the diastereomeric ratios observed in the tetrahydrofuran and oxepane reactions
we would have to decrease the temperature of our reaction to shift the Boltzman
distribution to the most thermodynamically stable conformer.
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Figure 4-2. Relative energy minima of the conformations of tetrahydropyran.
In the oxepane example we observed a 20 % isolated yield of the intended
product, however in this example we obtain only 46 % conversion of the starting
material by 1H NMR analysis at 24 hours. We isolated a secondary product and
determined the structure to be alkenone 4-50. We hypothesized alkenone
formation occurred after the formation of the oxepane product by the original
proposed SN2’ mechanism. The Au(III) likely coordinates to the allylic ether
present in the product, which acts to delocalize the -electrons to promote an
elimination to form an enol ether. Protodeauration of the complex followed by
tautomerization, and elimination yields the observed alkenone product 4-50.
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Scheme 4-7. Proposed mechanism for the formation of alkenone product 4-37.

Analysis of the scope of the Au(III)-catalyzed reaction to form saturated
oxygen heterocycles indicated this methodology is efficient for a broad range of
substrates. As predicted the optimized allylic ether leaving group dramatically
improved the diastereoselectivity of this reaction at room temperature for all
substrates, however tetrahydropyrans and oxepanes had a lower diastereomeric
ratio. Good isolated yields were reported though the catalyst loading was high. In
order to determine the efficiency of this reaction an investigation was performed
to optimize the conditions and analyze the reaction rate.
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4.4. Optimization of Conditions and Control Experiments
To determine the optimal catalyst loading, and to confirm if homogenous
Au(III) was the active catalyst a study was performed with mono-allylic diol
substrate 4-21a to form tetrahydropyran 4-33 (Equation 4-2, Table 4-2).
Quantitative GC yields were obtained in less than 10 minutes using only 1 mol %
of AuCl3 / 3 AgOTf (entry 2, Table 4-2). In comparison 1 mol % of
PPh3AuCl/AgOTf required 40 minutes to achieve a 94 % GC yield (entry 4, Table
4-2). This table also shows cationic gold(III) complex was the active species
because no or very minimal conversion was observed using AuCl3 and AgOTf
separately. Additionally, transformation was not reactive with AgCl, basic alumina
or MS 4 Å.
To test the robustness of the developed catalyst system a variety of
solvents were tested in open air using substrate 4-24 to form tetrahydropyran 433 (Equation 4-3, Table 4-3). The majority of solvents tested gave quantitative
yield of the product in less than 10 minutes with just 1 mol % of AuCl3 / 3 AgOTf.
Polar coordinating solvents like acetone, methanol and water (entries 7-9) were
not suitable solvents for the reaction. This is likely because the solvent strongly
coordinates to the Au(III) preventing the catalyst from interacting with the
substrate.
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(4-2)

Table 4-3. Catalyst loading and control experiments.
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(4-3)

Table 4-4. Solvent considerations.
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5. Gold(III)-Catalzed Cyclization to Form Spiroketals
5.1. Spiroketals in Nature
Spiroketals are a unique structural feature in which cyclic ethers are
connected by single carbon called the spiro carbon. Each of the ketal oxygens
joined by the spiro-carbon belongs to one of the rings. The spiroketal ring system
is an important structural feature observed in a myriad of natural products with
promising and diverse biological activity such as insect pheromones, polyether
ionophores, macrolide antibiotics, and steroidal saponins.80 Some examples of this
natural product which possess this spiroketal structural motif are tautomycin 5-1,81
okadaic acid 5-2, 82 and spongistatin 5-3 83 which are all protein phosphatase
inhibitors (Figure 5-1).
These rigid, structurally complex features often serve as pharmacophores
in biological systems due to the conformational constraint of these moieties making
them attractive targets in reaction methodology.84 The synthesis of spiroketals still
remains a significant challenge in synthesis and few examples of metal catalyzed
reactions to form these features have been reported.
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Figure 5-1. Spiroketal-containing natural products.

5.2. Conformational Aspects of Spiroketal Structures
The stereochemistry of spiroketals is thermodynamically influenced by the
anomeric effect.85 However, intramolecular hydrogen bonding, steric interactions
and chelation may also contribute to the conformation of these spirocyclic
systems.

86

The anomeric effect is described as the propensity of an

electronegative atom like oxygen at the anomeric carbon of a pyranose ring to
occupy the axial position of the ring. This orientation allows the lone pair of the
oxygen to interact with the * antibonding orbital of the C-O bond (Figure 5-2). If

57

the substituent is in the equatorial position of the ring this orbital interaction is not
possible making this a conformation much higher in energy. Each anomeric
interaction increases the stability by decreasing the total energy of the molecule
by approximately 1.4 – 2.4 kcal/mol.87

Figure 5-2. Possible positions of an electronegative hydroxyl substituent at the
tetrahydropyran anomeric carbon.
The 6,6-spiroketal core may exist in four different conformations which can
be interconverted by ring flipping (Figure 5-3). 88 The most thermodynamically
stable

conformation (A) has two

anomeric interactions. Two

possible

conformations exhibit one anomeric effect (B and C). The most thermodynamically
unfavorable isomer is the conformation with no anomeric effect (D).
The traditional method to synthesize spiroketals is the acid-catalyzed
cyclization of a dihydroxyketone (Equation 5-1). 89 This method is effective at
synthesizing the thermodynamically favorable spiroketals stereoisomers which
benefit from conformational anomeric effects.85 Since most synthetic targets have
this conformation this method is often effective for synthesis.
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Figure 5-3. Possible conformations of a spiroketal.
However, substrates with acid-labile functional groups limits the reaction
scope. Additionally, synthesis of nonanomeric or thermodynamically unfavorable
spiroketals are very challenging using this method.

(5-1)

5.3. Metal-Catalyzed Spiroketalization
Cationic metal complexes have been found to be effective for the Lewis
acid-catalyzed cyclization to form spiroketals. Floreancig and co-workers
described the application of the thermodynamic stereocontrolled process to
synthesize spiroketals by transposition/oxa-Micahel addition. They reported high
stereocontrol in the synthesis of spiroketals from allylic alcohols using rhenium
(VII) oxide (Scheme 5-1). 90 In 2010, Cossy described a Fe(III)-catalyzed
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diastereoselective formation of spiroketals from allylic acohols in good yield.91 This
cyclization was proposed to proceed through a carbocation intermediate which
allowed for the thermodynamically favorable diastereomer but excluded this
reaction from stereo-retention towards enantioselective products. Aponick and coworkers have reported on the Au(I)-catalyzed spiroketalization of protected
monoallylic propargyl alcohols.39 This approach to synthesize unsaturated
spiroketal structures addressed the regioselectivity issues commonly reported in
metal-catalyzed spiroketalization of alkynes.

Scheme 5-1. Selected examples of metal-catalyzed spiroketalizations.

The selected examples are powerful synthetic methods to yield spiroketals,
but these synthetic methodologies are limited to the formation of the specific
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substrates, and there are very few reports of the formation of reaction cascade to
form bis-spiroketals.

5.4. Gold(III)-Catalyzed Spiroketalization of Monoallylic Ketodiols
The recent work of a graduate student from Aponick’s group sought to
synthesize spiroketals from monoallylic ketodiols using cationic metals. Palmes
discovered Pd(II) was the best catalyst in this reaction (Scheme 5-2), however
homogenous Au(III) was not tested in this reaction.92 Au(I) was ruled out early in
the investigation as being less efficient though it successfully catalyzed the
reaction although in poor yield. Based on the results presented in this thesis we
hypothesized homogenous Au(III) complexes may be able to activate the carbonyl
and allylic alcohol moiety towards the formation of spiroketals, and the more
synthetically difficult bis-spiroketals utilizing a similar reaction cascade.

Scheme 5-2. Selected examples metal-catalyzed spiroketalization of monoallylic
ketodiols.
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To test our hypothesis, an unsubstituted monoallylic ketodiol was
synthesized from commercially available -valerolactone by formation of the
corresponding Weinreb amide 5-15 and protection of the primary alcohol to afford
the t-butyldimethylsilyl ether 5-16 (Scheme 5-3). Nucleophilic addition of a
Grignard reagent prepared from 5-bromopentne to the substrate yielded 5-17.
Which was then used in olefin cross-metathesis with Z-2-butene-1,4-diol to afford
the mono-allylic ketodiol 5-18. The optimized allylic ether leaving group 2,6dimethyl-4-nitrophenol was installed using Mitsunobu etherification, and the
protecting group was removed to obtain the desired substrate 5-20.

Scheme 5-3. Synthesis of mono-allylic ketodiol 5-20.
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Substrate 5-20 was then treated with 2 mol % of the catalyst AuCl3 / 3 AgOTf
in CDCl3 with basic alumina added as a dessicant. TLC showed complete
consumption of the starting material after just 5 minutes. However, due to the
polarity of the compounds detected it was believed that this was the hemiketal that
had been formed by the Lewis acid activation of the carbonyl, and the reaction was
allowed to react overnight in order to form the spiroketal. The reaction was checked
by 1H NMR after 15 hours to show only the hemiketal had formed (Scheme 5-4).
After heating the reaction at reflux for an additional 24 hours no spiroketal was
formed. The hemiketal was isolated in 62% yield with good diastereoselectivity,
however this yield is the result of the equilibrium formed between the hemiketal
and the starting material in the presence of a Lewis acid.

Scheme 5-4. Au(III)-catalyzed spiroketallization of 5-20.

We believed it was unlikely the oxophilicity of Au(III) was preventing the
reaction from progressing, and hypothesized that the sterically bulky allylic ether
leaving group was preventing nucleophilic attack with the sterically bulky
thermodynamically favored, axial, anomeric alcohol. Therefore, a smaller allylic
ether leaving group could decrease the steric bulk and allow the reaction to
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progress to completion. Substrate 5-22 was synthesized by olefin metathesis of 517 with Z-1,4-diacetoxy-2-butene and deprotection of the TBS ether. The acetoxy
leaving group could enhance the reactivity of the allylic oxygen, while decreasing
the steric bulk of this functional group.

Scheme 5-5. Synthesis of substrate 5-22.
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6. Centrolobine
6.1. Introduction and Background of Centrolobine
The Au(III) catalyst methodology developed in this thesis was utilized
toward the total synthesis of centrolobine. In 1959, a group of scientists discovered
extracts from the heartwood of Centrolobium robustum exhibited bacteriostatic
activity. It was not until 1964 that one of the active ingredients was extracted,
isolated,

and

characterized

as

2[β(p-hydroxyphenyl)ethyl-2-(p-

methoxyphenyl)tetrahydropyran, referred to as (+)-centrolobine ((+)-6-1, Figure 61).93

Figure 6-1. (+)-Centrolobine.
Centrolobine has since been found in numerous plants in the Brazilian
Amazon and the compound has acute antibiotic and antifungal activity, therefore
making it a promising drug candidate or lead for antibiotics. 93,

94 , 95

Both

enantiomers, (+)- and (–)-centrolobine, are active antibiotic agents and have been
isolated from many different trees, primarily Centrolobium robustum and
Centrolobium tomentosum. 93,94,95 Additionally, (–)-centrolobine has recently been
isolated from the stems of a completely different genus, Brosimum potabile.96
The scientific community has developed an interest in the synthesis of this
compound, and several total syntheses have been achieved. 97 In the multiple
synthetic pathways devised there have been many different methods by which the
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central tetrahydropyran ring of centrolobine has been formed.97, 98 , 99

We

hypothesized that we would be able to incorporate our diastereoselective Au(III)catalyzed etherification in a new stereoselective route towards centrolobine.
The absolute configuration of centrolobine was first determined in 2002 by
the first enantioselective total synthesis of (–)-centrolobine (Scheme 6-1).98 The
optically pure keto sulfoxide (R)-6-4 was prepared by condensation of glutaric
anhydride (6-2) and (R)-6-3. This intermediate was then esterified with
dimethylsulfate and potassium carbonate to obtain (R)-6-5. The 1,3 diketone was
then stereoselectively reduced with DIBAL-H and ZnBr2 to obtain 6-6 in high
diastereomeric excess. From the proposed mechanism,100 and the characteristic
1H

NMR spectrum for each diastereomer, 101 the absolute configuration of the

hydroxylic carbon on 6-6 was assigned as R stereoisomer. In order to form the
tetrahydropyran ring, this group followed the work of Olah102 and Nicolaou.103 By
treating the hydroxyl ketone with excess Et3SiH and TMSOTf they were able to
prepare the respective unsymmetrical cyclic ether by reductive condensation of
carbonyl compounds. The stereospecificity of the etherification was directed by the
R hydroxyl group of 6-7, and the syn stereochemistry was assigned by 1H NMR
Nucear Overhauser enhancement experiments. This stereochemistry was
conserved through the rest of the 9 step synthesis to obtain (–)-centrolobine in
26% overall yield.
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Scheme 6-1. First enantioselective total synthesis of (–)-centrolobine.

6.2. Total Synthesis of (±)-Centrolobine
Heidi Dimmitt, a prior Vyvyan group member, had developed a concise
synthesis of centrolobine involving Au(I)-catalyzed tetrahydropyran formation
(Scheme 6-2).12 The synthetic approach began with a nucleophilic addition of a
Grignard reagent prepared from 5-bromo-1-pentene with p-anisaldehyde to form
6-12. Olefin-metathesis of the terminal alkene (Z)-2-butene-1,4-diol using Grubbs’
2nd generation catalyst formed 6-13. The primary alcohol was reacted in a
Mitsunobu etherification with 6-14 to from allyl aryl ether 6-15. Au(I) catalyzed
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cyclization of this intermediate yield the central tetrahydropyran of centrolobine as
a single diastereomer due to the sterically bulky leaving group 6-14. The terminal
alkene was coupled to the THP protected 4-iodophenol using an alkyl Suzuki
coupling to yield 6-17. Deprotection of the THP-protecting group completed the 6step synthesis of (±)-centrolobine with an overall yield of 2%.

Scheme 6-2. Synthesis of (±)-centrolobine utilizing gold(I)-catalyzed ring formation.
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Due to the low overall yield in the total synthesis of (±)-centrolobine we
believed we could improve the synthetic pathway by utilizing fewer steps that
promoted higher yields of reaction intermediates. First, we designed the synthesis
around a the Au(III)-catalyzed cyclization step. In this design we hypothesized the
sterically bulky allylic

aryl

group

in

centrolobine

would

enhance

the

diastereoselectivity of the reaction without installation of a sterically bulky leaving
group. Second we hypothesize coupling the east and west fragments of
centrolobine could be easily accomplished by an olefin metathesis reaction as the
terminal alkene of the west fragment would be a type I fast homodimerization
species, while the east fragment would be a type II slow homodimerization species.
Lastly, these fragments could be assembled in high yield using a simple
nucleophilic addition with the corresponding Grignard reagent (Scheme 6-3).
Furthermore, we hypothesized that we may be able to obtain an enantiopure
centrolobine by utilizing an enantioselective Corey-Bakshi-Shibata reduction to
form the corresponding enantiopure western fragment.
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Scheme 6-3. Retrosynthetic analysis of centrolobine towards a more efficient total
synthesis with Au(III).

The synthesis began with the nucleophilic addition of prepared Grignard
reagent. The western fragment was synthesized by a method similar to the
pathway devised by Dimmit; by addition of 6-11 to p-anisaldehyde 6-10, however
with an improved yield (85%, Scheme 6-4). The eastern fragment was synthesized
by addition of vinyl magnesium bromide 6-18 to 6-17 in high yield.\
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Scheme 6-4. Nucleophilic addition with Grignard reagents in the preparation of
intermediates 6-12 and 6-18.

Unfortunately, when these substrates were subjected to olefin metathesis
with Grubbs 2nd generation catalyst 6-18 proceeded through a rapid
homodimerization/isomerization pathway to form the oxidized and conjugated
species 6-19 (Equation 6-1). This side reaction occurred even in the presence of
additives like p-benzoquinone and acetic acid, which have been reported to
suppress undesirable olefin isomerization.73 The formation of this species was
likely also driven by Le Châtelier's principle as the compound exhibited poor
solubility in DCM and chloroform, and readily precipitated out of solution.

(6-1)

In order to prevent this undesirable product and make the reaction more
robust and efficient, a protecting group was installed. In the course of this thesis
work it was discovered that allylic acetoxy groups are exceptionally resistant to
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olefin isomerization and may be used in stoichiometric equivalents for high yields.
Therefore, we installed an acetoxy protecting group on to 6-18 by reaction of acetic
anhydride and dimethylaminopyridine to synthesize 6-19 (Scheme 6-5).
When 6-12 and 6-19 were subjected to olefin metathesis conditions the
reaction proceeded to the product 6-20 without the formation of any observable
side products. Though the yield for this reaction was low, unreacted starting
materials were recovered indicating the reaction had not gone to complete
conversion. This can easily be improved by using a higher catalyst loading, a
higher temperature and a longer reaction time.
The substrate 6-20 was then cyclized in one minute with just 1 mol % AuCl3
/ 3 AgOTf as a single diastereomer 6-21. Hydrogenation to reduce the olefin and
remove the benzyl ether protecting group in single step was attempted on 6-21
using palladium on carbon and hydrogen gas. After 24 hours a nearly complete
conversion of the starting material was observed by TLC, however a mixture of
products was formed, none of which was the intended product (±)-centrolobine.
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Scheme 6-5. Synthetic pathway to form (±)-centrolobine.

Future work will attempt to improve the synthetic pathway of this reaction
towards the total synthesis of (±)-centrolobine. First, the acetate protection may be
performed with the in situ generated oxygen anion from the nucleophilic addition
reaction. This would reduce the number of total steps and should increase the total
yield across the two reactions. Though the yield of the olefin metathesis reaction
was only 12 % there was good recovery of the starting materials (81 % recovered
6-19, and 41% recovered 6-12). Therefore, adjusting the reaction conditions to
allow for increased catalyst loading, increased reaction temperature and longer
reaction time should improve the observed yield in this reaction. The Au(III)catalyzed cycloetherification to form 6-21 had a low isolated yield though complete
conversion was observed by TLC after 1 minute. This is due to the complex mixture
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of minor products that formed in the approximately 15 minutes during the analysis
of the reaction mixture by TLC. These undesirable side reactions may be
prevented by reducing the reaction temperature, however a more detailed analysis
of these minor products is required to determine the mechanism of side product
formation. Lastly, though the hydrogenation was ineffective in this case the
hypothesis is that excess hydrogenation may have cause undesirable side
reactions to occur. Therefore, performing the hydrogenation under more mild
conditions may allow access to the desired natural product (±)-centrolobine.
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7. Conclusions and Future Work
The work presented in this thesis has demonstrated the synthesis of butyrolactones and saturated oxygen heterocycles utilizing homogenous Au(III)
complexes. We were able to synthesize the substrates by utilizing readily available
starting materials, and efficient synthetic pathways. In the synthesis of butyrolactones we observed electron donating, cation accepting ester substituents
enhanced the reactivity in Au(III) catalysis. We were able to demonstrate the use
of an electron withdrawing, sterically bulky allylic ether leaving groups allowed for
increased reactivity in Au(III) catalyzed cyclizations to form -butyrolactones. The
steric bulk of these allylic ether leaving groups allowed for stabilization of the
transition state to increase diastereoselectivity in the synthesis of saturated oxygen
heterocycles. This reaction performed smoothly in the presence of many different
functional groups. We then sought to use the optimized conditions in more difficult
saturated oxygen heterocycles structural moieties observed in complex synthetic
targets.
In the attempt to synthesize spiroketal structural features we observed that
Au(III) was an exceptional Lewis acid for activation of the ketone for nucleophilic
addition, however the electron withdrawing allylic ether leaving group may have
prevented the final spiroketalization due to steric bulk. The reactivity of Au(III)
catalyst system was effectively used to synthesize the central tetrahydropyran
structural feature in (±)-centrolobine.
Based on these results we have hypothesized new routes in which this
Au(III) catalyst system may be employed. We believe the oxophilicity of Au(III) is
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potential advantageous in the catalytic activation of certain oxygen functional
groups like carbonyls, epoxides, and , – unsaturated carbonyls, which could
introduce new reaction methodologies. Activation of these structural features could
enable access to synthetically difficult molecular structures.
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8. General Experimental Procedures
All procedures involving air- or moisture-sensitive reagents were performed
in oven dried glassware under an argon atmosphere. Ether, THF, CH 2Cl2 and
toluene were dried by passing through a column of activated alumina using an
Innovative Technology Pure SolvTM 400 Solvent Purification System. In all
procedures, unless otherwise noted, concentration was performed using rotary
evaporation. Dessicants like MgSO4 and NaSO4 were removed using gravity
filtration and fluted filter paper (VWR Qualitative Filter Paper 415).
For purifications, column diameters, and solvent mixtures were given (for
example “40 mm column, 6:1 Hex: EtOAc”). Flash chromatography was performed
with hand packed columns of silica gel (Silicycle, Chemical Division, 230-400
mesh). Thin Layer Chromatography was done using Sorbent Technologies 200
m silica layer fluorescence UV254 TLC plates.
1H

and 13C NMR spectra were acquired on either Varian Mercury (300 MHz)

or UNITYINOVA (500 MHz) spectrometers. All chemical shifts were reported in ppm,
and all coupling constants are reported in Hertz.

1H

chemical shifts were

referenced to tetramethylsilane (TMS) at 0.00 ppm. 1H NMR data are reported in
the following format: chemical shift [integral, multiplicity (s = singlet, d = doublet, t
= triplet, q = quartet, m = multiplet), coupling constant(s) J, proton assignment].
13C

NMR spectra are referenced to CDCl3 at 77.1 ppm.
Infrared spectra were obtained on a Thermo Scientific Nicolet iS10 FT-IR

spectrometer with Smart iTR attachment. All absorptions are reported in cm -1.
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Absorbances in the IR spectrum are referenced to as: w = weak, m = medium, s =
strong, and br = broad.
High resolution mass spectrometry was performed by the Mass
Spectrometry Facility at the University of California, Irvine.
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Preparation of 2,6-dimethyl-4-nitrophenol

Notebook Entry: RDLB037
2,6-dimethylphenol (20.0.34 g, 164 mmol), concentrated sulfuric acid (18M,
30 mL) were added to a 500 mL Erlenmeyer flask and stirred until the solid was
dissolved forming a pink solution. After 5 minutes, the solution solidified to a pink
solid. Glacial acetic acid (17.4 M, 100 mL) was added to dissolve the pink solid.
The reaction mixture was stirred until solution was homogenous and then
submerged in an ice bath. A mixture of nitric acid (15 mL, 16M) and sulfuric acid
(15 mL, 18M) was added drop wise over a period of 1 hour. Reaction vessel was
taken out of ice bath and allowed to slowly warm to room temperature. Na 2CO3
was added slowly until pH was around 3. The reaction mix was vacuum filtered
over filter paper and rinsed with cold water to provide 4-nitro-2,6-dimethylphenol
(15.8941 g, green solid 58 %).
FTIR: 3030 (sp2 C-H stretch), 2920 (sp3 C-H stretch), 1588/1517 (N-O stretch) cm1.
1H

NMR (CDCl3, 500 MHz): δ 7.93 (s, 2H), 2.32 (s, 6H) ppm.

13C

NMR (CDCl3, 125 MHz): δ 157.9, 124.5, 123.7, 77.3, 77.0, 76.8, 15.9 ppm.
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Preparation of 1-cyclohexylhex-5-en-1-ol

Notebook Reference: RDLA202
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged
with magnesium turnings (546.9 mg, 22.50 mmol) and fitted with a reflux
condenser and placed under argon. THF (15 mL) was added via syringe followed
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the
magnesium. 5-bromo-1-pentene (1.78 mL, 15.0 mmol) was diluted in 10 mL and
added drop wise over 15 minutes. The reaction was then heated at reflux for 1
hour.

The

reaction

was

cooled

to

room

temperature

and

cyclohexyanecarboxaldehyde (1.91 mL, 15.8 mmol) was added via syringe and
the reaction was heated at reflux for 2 hours. The reaction was cooled to room
temperature, poured over 10% HCl (50 mL), extracted with ether (3 × 30 mL), dried
over magnesium sulfate, and concentrated in vacuo. The resultant crude oil was
purified via flash chromatography (6:1 Hex:EtOAc, Rf = 0.18) to afford a clear,
colorless oil (2.4761 g, 13.583 mmol, 91%).
FTIR (ATR): 3350 (br, OH stretch), 3076 (w, vinyl CH stretch), 2922, 2852 (m, alkyl
CH stretch), 1640, 1449 (m, vinyl C-C stretch), 1316, 1261 (w, alkyl C-C stretch),
1086 (w, CO stretch), 991, 996, 908 (m) cm-1.
NMR (500 MHz, CDCl3): δ 5.83 (ddt, J = 17.0, 10.3, and 3.5, 2H), 5.04 (dd, J =
17.2, 1.6 1H), 4.95 (dd, J = 8.9, 1.1,1H), 3.60 (1H, sept., J 3.6), 2.07 (4H, q, J 5.1),
1.52-1.43 (8H, m) ppm.
1H

NMR (125 MHz, CDCl3): δ 138.9, 114.7, 75.7, 43.8, 33.3, 30.4, 29.3, 27.8, 26.6,
26.5, 26.4, 26.2 ppm.
13C
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Prepartation of (E)-7-cyclohexylhept-2-ene-1,7-diol

Notebook Reference: RDLA206
An oven dried 100 mL round bottom flask with a stir bar was charged with
p-benzoquinone (88.1 mg, 0.815 mmol) and Grubbs 2nd Generation Catalyst
(230.6 mg, 0.2716 mmol) and placed under argon. DCM (25 mL) was added via
syringe followed by (Z)-but-2-ene-1,4-diol (6.70 mL, 81.49 mmol) and 1cyclohexylhex-5-en-1-ol (2.4761 g, 13.58 mmol). The reaction was stirred at room
temperature for 2 days. An additional 4 equivalents of (Z)-but-2-ene-1,4-diol was
added every 24 h, and the reaction was monitored by TLC for consumption of
starting material. The reaction mixture was concentrated in vacuo, and purified via
flash chromatography (2:1 Hex:EtOAc, Rf = 0.41) to afford a colorless oil (1.309 g,
7.725 mmol, 57 %). E:Z ratio determined to be 6:1 by comparison of 1H NMR
chemical shifts at 4.07 and 4.11 ppm.
FTIR (ATR): 3383 (br), 2924 (w), 1670 (m), 1449 (m), 969 (m) cm-1.
NMR (500 MHz, CDCl3): δ 5.74-5.58 (m, 2H), 4.07 (d, J = 4.5 Hz, 2H), 3.363.32 (m, 1H), 2.10-2.03 (m, 2H), 1.80-0.95 (m, 17H) ppm.
1H

NMR (125 MHz, CDCl3): δ 132.5, 129.2, 75.8, 63.2, 43.5, 33.3, 32.1, 29.1, 27.7,
26.4, 26.2, 26.1, 25.3 ppm.
13C
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Preparation of 1-cyclohexylpent-4-en-1-ol

Notebook Reference: RDLA203
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged
with magnesium turnings (546.9 mg, 22.50 mmol) and fitted with a reflux
condenser and placed under argon. THF (15 mL) was added via syringe followed
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the
magnesium. 4-bromo-1-butene (1.53 mL, 15.0 mmol) was diluted in 10 mL and
added drop wise over 15 minutes. The reaction was heated at reflux for 1 hour.
The reaction was cooled to room temperature and cyclohexyanecarboxaldehyde
(1.91 mL, 15.8 mmol) was added via syringe and the reaction was heated at reflux
for 2 hours. The reaction was cooled to room temperature, poured over 10% HCl
(50 mL), extracted with ether (3 × 30 mL), dried over magnesium sulfate, and
concentrated in vacuo. The resultant crude oil was purified via flash
chromatography (6:1 Hex:EtOAc, Rf = 0.18) to afford a clear, colorless oil (2.107
g, 12.52 mmol, 83%).
FTIR (ATR): 3350 (br, OH stretch), 3076 (w, vinyl CH stretch), 2922, 2852 (m, alkyl
CH stretch), 1640, 1449 (m, vinyl C-C stretch), 1316, 1261 (w, alkyl C-C stretch),
1086 (w, CO stretch), 991 (m), 996 (m), 908 (m) cm-1.
NMR (500 MHz, CDCl3): δ 5.83 (ddt, J = 17.0, 10.3, 3.5, 1H), 5.04 (dd, J = 17.2,
1.6, 1H), 4.95 (dd, J = 8.9, 1.1, 1H), 3.60 (septet, J = 3.6, 1H), 2.07 (q, J = 5.1, 4H),
1.52-1.43 (m, 8H) ppm.
1H

NMR (125 MHz, CDCl3): δ 138.9, 114.7, 75.7, 43.8, 33.3, 30.4, 29.3, 27.8, 26.6,
26.5, 26.4, 26.2 ppm ppm.
13C
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Preparation of (E)-6-cyclohexylhex-2-ene-1,6-diol

Notebook Reference: RDLA207
An oven dried 50 mL round bottom flask with a stir bar was charged with pbenzoquinone (74.4 mg, 0.688 mmol) and Grubbs 2nd Generation Catalyst (194.7
mg, 0.2293 mmol) and placed under argon. DCM (25 mL) was added via syringe
followed by (Z)-but-2-ene-1,4-diol (5.66 mL, 68.8 mmol) and 1-cyclohexylpent-4en-1-ol (1.9298 g, 11.47 mmol). The reaction was stirred at room temperature for
2 days. An additional 4 equivalents of (Z)-but-2-ene-1,4-diol was added every 24
h, and the reaction was monitored by TLC for consumption of starting material.
The reaction mixture was concentrated in vacuo, and purified via flash
chromatography (1:1 Hex:EtOAc, Rf =0.41 ) to afford a colorless oil (368.6 mg,
1.859 mmol, 16%). E:Z ratio determined to be 6:1 by comparison of 1H NMR
chemical shifts at 4.07 and 4.11 ppm.
FTIR (ATR): 3330(br, OH stretch), 2922 (s, vinyl CH stretch), 2851 (s, alkyl CH
stretch), 1448 (m, vinyl C-C stretch), 1087, 1000 (s, CO stretch), 968 (s, vinyl CH
oop bend) cm-1.
NMR (500 MHz, CDCl3): δ 5.65 (m, 2H), 4.07 (d, J = 4.5 Hz, 2H, OCH), 3.34
(m, 1H), 2.06 (m, 2H), 1.75-0.94 (m, 13H) ppm.
1H

NMR (125 MHz, CDCl3): δ 133.0, 129.3, 76.1, 63.7, 43.6, 33.6, 29.3, 27.7, 26.5,
26.4, 26.2, 25.5 ppm.
13C
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Preparation of (E)-1-cyclohexyl-6-(2,6-dimethyl-4-nitrophenoxy)hex-4-en-1ol

Notebook Reference: RDLA215
An oven dried 50 mL flask with a stir bar was charged with
triphenylphosphine (550.8 mg, 2.100 mmol) and 2,6-dimethyl-4-nitrophenol (367.8
mg, 2.200 mmol), and placed under argon. Dry THF (10 mL) was added to the
flask via syringe followed by (E)-7-cyclohexylhept-2-ene-1,7-diol (368.6 1.859
mmol). The reaction flask was cooled to -78° C (dry ice/acetone bath). DIAD (0.41
mL, 2.1 mmol) was diluted with dry THF (10 mL) and added dropwise over 15
minutes. The reaction was stirred for 48 h. The reaction mixture was diluted with
ether, washed with 10% NaOH solution (3 × 30 mL) and dried over anhydrous
magnesium sulfate. The mixture was gravity filtered, concentrated in vacuo. The
crude product was purified via column chromatography (2:1 Hex:EtOAc) to give
(E)-1-(hex-2-en-1-yloxy)-2,4-dimethylbenzene (102 mg, 0.294 mmol,16 %).
FTIR (ATR): 3402 (br), 2948 (m), 2934 (m) 2867 (m), 1588, 1508, 1472 (m), 1344,
1211 (s), 1100, 1078 (s) 963, 902 (s) cm-1.
NMR (500 MHz, CDCl3): δ 7.95 (s, 2H), 5.71 (ddddd, J = 13.4, 7.9, 6.7, 1.3, 1.3,
1H), 5.58 (ddddd, J = 12.6, 8.4, 5.9, 1.5, 1.5,1H), 5.19 (dd, J = 4.6, 2.0, 2H), 4.14
(ddd, J = 11.8, 5.7, 1.0, 1H), 3.92 (m, 2H), 2.33 (s, 6H), 2.15-0.96 (m, 12H) ppm.
1H

NMR (125 MHz, CDCl3): δ 158.0, 134.5, 126. 5, 124.5, 125.7, 103.1, 67.8 67.0,
43.5, 33.6, 32.3, 29.3, 27.6, 26.4, 25.2, 23.6, 15.9 ppm.
13C
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Preparation of 2,2-dimethyloct-7-en-3-ol

Notebook Reference: RDLA222
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged
with magnesium turnings (1.0338 g, 42.534 mmol) and fitted with a reflux
condenser and placed under argon. THF (15 mL) was added via syringe followed
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the
magnesium. 5-bromo-1-butene (2.73 mL, 23.0 mmol) was diluted in 10 mL and
added drop wise over 15 minutes. The reaction was then heated at reflux for 1
hour. The reaction was cooled to room temperature and pivaldehyde (2.00 mL,
18.41 mmol) was added via syringe and the reaction was heated at reflux for 2
hours. The reaction was poured over 10% HCl (50 mL), extracted with ether (3 ×
30 mL), dried over magnesium sulfate, and concentrated in vacuo. The resultant
crude oil was purified via flash chromatography (6:1 Hex:EtOAc, R f = 0.46) to
afford a clear, colorless oil (1.4026 g, 8.98 mmol, 50 %).
FTIR (ATR): 3355 (br), 2953 (w), 2869 (m), 1640 (s), 1479, 1364 (s), 1076, (s),
908 (s) cm-1.
NMR (500 MHz, CDCl3): δ 5.92 – 5.78 (m, 1H), 5.06 (dq, J = 17.1, 1.7 Hz, 1H),
4.97 (ddt, J = 10.2, 2.3, 1.2 Hz, 1H), 3.21 (dd, J = 10.6, 1.9 Hz, 1H), 2.38 – 2.27
(m, 1H), 2.11 (ddtt, J = 14.5, 8.7, 7.2, 1.4 Hz, 1H), 1.61 (dddd, J = 13.8, 9.0, 7.1,
1.9 Hz, 1H), 1.36 (dddd, J = 13.9, 10.6, 8.7, 5.3 Hz, 1H), 1.03 – 0.77 (m, 10H),
0.75 (s, 1H) ppm.
1H

NMR (125 MHz, CDCl3): δ 138.9, 114.5, 79.8, 345.0, 33.8, 30.9, 26.4, 25.7
ppm.
13C
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Preparation of (E)-8,8-dimethylnon-2-ene-1,7-diol

Notebook Reference: RDLA230
An oven dried 100 mL round bottom flask with a stir bar was charged with
p-benzoquinone (53.9 mg, 0.500 mmol) and Grubbs 2nd Generation Catalyst
(141.3 mg, 0.1665 mmol) and placed under argon. DCM (25 mL) was added via
syringe followed by (Z)-but-2-ene-1,4-diol (2.74 mL, 33.30 mmol) and 2,2dimethyloct-7-en-3-ol (1.301 g, 8.324 mmol). The reaction was stirred at room
temperature for 2 days. An additional 4 equivalents of (Z)-but-2-ene-1,4-diol was
added every 24 h, and the reaction was monitored by TLC for consumption of
starting material. The reaction mixture was concentrated in vacuo, and purified via
flash chromatography (3:1 Hex:EtOAc, Rf =0.29 ) to afford a colorless oil (1.131g,
6.071 mmol, 73%). E:Z ratio determined to be 6:1 by comparison of 1H NMR
chemical shifts at 4.11 and 4.14 ppm.
FTIR (ATR): 3340 (br), 2948, 2867 (m), 1460, 1393, 1363, 1316 (w), 1080, 1001
(s), 969, 908 (s) cm-1.
1H NMR (500 MHz, CDCl ): δ 5.77 – 5.63 (m, 1H), 4.11 (d, J = 5.3 Hz, 2H), 3.21
3
(d, J = 10.3 Hz, 1H), 2.20 – 2.03 (m, 2H), 1.73 – 1.63 (m, 1H), 1.61 – 1.51 (m, 1H),
1.44 (dddd, J = 18.6, 12.2, 9.9, 5.7 Hz, 2H), 1.34 – 1.22 (m, 1H), 0.91 (t, J = 2.0
Hz, 9H).
13C NMR (125 MHz, CDCl ): δ 133.3, 129.3, 79.8, 63.9, 34.9, 32.4, 31.2, 26.6, 25.p
3
ppm.
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Mitsunobu

Etherification:

Preparation

of

(E)-9-(2,6-dimethyl-4-

nitrophenoxy)-2,2-dimethylnon-7-en-3-ol

Notebook Reference: RDLA244
An oven dried 50 mL flask with a stir bar was charged with
triphenylphosphine (550.6 mg, 2.100 mmol) and 2,6-dimethyl-4-nitrophenol (367.8
mg, 2.200 mmol), and placed under argon. Dry THF (10 mL) was added to the
flask via syringe followed by (E)-8,8-dimethylnon-2-ene-1,7-diol (372.6 mg, 2.0
mmol). The reaction flask was cooled to -78° C (dry ice/acetone bath). DIAD (0.41
mL, 2.1 mmol) was diluted with dry THF (10 mL) and added dropwise over 15
minutes. The reaction was stirred for 48 h. The reaction mixture was diluted with
ether, washed with 10% NaOH solution (3 × 30 mL) and dried over anhydrous
magnesium sulfate. The mixture was gravity filtered, concentrated in vacuo. The
crude product was purified via column chromatography (1 ½ in width, 18 in long
column,

2:1

Hex:EtOAc)

to

give

((E)-9-(2,6-dimethyl-4-nitrophenoxy)-2,2-

dimethylnon-7-en-3-ol as a yellow oil (337.4 g, 1.006 mmol, 50 %).
FTIR (ATR): 3413 (br), 3119 (w) 2949 (m), 2867 (m), 1588, 1507, 1473 (m), 1345,
1308 (s), 1277, 1211, 1100, 1078 (s), 964, 903,767, 746 (m) cm-1.
NMR (500 MHz, CDCl3): δ 7.92 – 7.87 (m, 1H), 5.87 – 5.68 (m, 1H), 4.35 –
4.30 (m, 1H), 3.22 – 3.12 (m, 1H), 2.34 (t, J = 0.8 Hz, 3H), 2.22 – 2.05 (m, 1H),
1.76 – 1.64 (m, 0H), 1.58 – 1.35 (m, 1H), 1.32 – 1.19 (m, 1H), 0.89 (s, 4H) ppm.
1H

NMR (125 MHz, CDCl3): δ 161.5, 143.4, 136.2, 132.6, 125.0, 124.2, 124.1,
79.7, 73.5, 35.0, 32.3, 30.9, 26.4, 25.7, 25.7, 16.8 ppm.
13C

87

Preparation of 2,2-dimethylhept-6-en-3-ol

Notebook Reference: RDLA223
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged
with magnesium turnings (1.0338 g, 42.534 mmol) and fitted with a reflux
condenser and placed under argon. THF (15 mL) was added via syringe followed
by dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the
magnesium. 4-bromo-1-butene (2.58 mL, 23.0 mmol) was diluted in 10 mL and
added drop wise over 15 minutes. The reaction was then heated at reflux for 1
hour. The reaction was cooled to room temperature and pivaldehyde (2.00 mL,
18.4 mmol) was added via syringe and the reaction was heated at reflux for 2 hours.
The reaction was cooled to room temperature, poured over 10% HCl (50 mL),
extracted with ether (3 × 30 mL), dried over magnesium sulfate, and concentrated
in vacuo. The resultant crude oil was purified via flash chromatography (6:1
Hex:EtOAc, Rf = 0.40) to afford a clear, colorless oil (1.2454 g, 8.76 mmol, 48 %).
FTIR (ATR): 3382 (br), 3078 (w), 2952, 2869 (m), 1449 (s), 1393, 1364 (s), 1075,
1005 (s), 909 (s) cm-1.
NMR (500 MHz, CDCl3): δ 5.83 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.02 (dq, J =
17.1, 1.7 Hz, 1H), 4.96 (ddt, J = 10.2, 2.3, 1.3 Hz, 1H), 3.19 (dq, J = 10.6, 1.9 Hz,
1H), 2.18 – 2.01 (m, 2H), 1.75 – 1.63 (m, 1H), 1.54 (dddd, J = 13.5, 10.1, 6.0, 1.9
Hz, 2H), 1.50 – 1.34 (m, 1H), 1.33 – 1.19 (m, 1H), 0.90 (d, J = 0.7 Hz, 9H) ppm.
1H

13C

NMR (125 MHz, CDCl3): δ 138.9, 114.7, 79.3, 34.9, 31.3, 30.7, 25.7 ppm.
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Preparation of 2,2-dimethylhept-6-en-3-ol

Notebook Reference: RDLB160
An oven dried 50 mL tube with stir bar was charged with magnesium
turnings (729.2 mg, 30.00 mmol) and placed under argon. THF (15 mL) was added
via syringe and 5-bromo-1-butene (1.74 mL, 15.0 mmol) was diluted in 10 mL and
added drop wise over 15 minutes. The reaction was then heated at reflux for 1
hour. The reaction was cooled to 0 ˚C and benzaldehyde (1.02 mL, 10.00 mmol)
was added dropwise via syringe and allowed to warm to room temperature over 2
hours. The reaction was quenched with 10% HCl (50 mL), extracted with ether (3
× 30 mL), dried over magnesium sulfate, and concentrated in vacuo. The resultant
crude oil was purified via flash chromatography (9:1 Hex:EtOAc, Rf = 0.3 in 9:1
Hex:EtOAc) to afford a clear, colorless oil (1.5251 g, 8.65 mmol, 87 %).
FTIR: 3345 (br), 3063, 3028 (w), 2934, 2860 (w), 1449 (s), 1393, 1364 (s), 1075,
1005 (s), 909 (s) cm-1.
NMR (CDCl3, 500 MHz): δ 7.37 (s, 2H), 7.44 – 7.26 (m, 2H), 5.81 (ddt, J = 16.9,
10.2, 6.7 Hz, 1H), 5.06 – 4.94 (m, 2H), 4.71 (ddd, J = 8.1, 5.7, 2.6 Hz, 1H), 2.15 –
2.05 (m, 2H), 1.92 – 1.66 (m, 3H), 1.62 – 1.50 (m, 1H), 1.42 (ddtd, J = 13.1, 10.5,
7.4, 5.6 Hz, 1H) ppm.
1H

NMR (CDCl3, 500 MHz): δ 144.8, 138.6, 128.5, 125.9, 114.7, 74.6, 38.5, 33.6,
25.1 ppm.
13C

89

Preparation of (E)-7-hydroxy-7-phenylhept-2-en-1-yl acetate

Notebook Reference: RDLB174
Grubbs 2nd generation catalyst (90.3 mg, 0.106 mmol) and p-benzoquinone
(57.5 mg, 0.532 mmol) were charged in a flame dried 25 mL flask with stir bar and
placed under argon. Anhydrous DCM (10 mL) was added via syringe, followed by
a mixture of 4-20a and Z-1,4-diacetoxy-2-butene. The syringe was rinsed twice
with DCM into the flask. A reflux condenser was fitted to the flask and the reaction
was heated at reflux overnight. The reaction was cooled to room temperature,
filtered through a plug of silica, rinsed with EtOAc, and concentrated in vacuo. The
crude oil was purified by flash chromatography (6-3:1 Hex:EtOAc,Rf = 0.16 in 3:1
Hex:EtOAc). E:Z ratio determined to be 5:1 by comparison of 1H NMR chemical
shifts at 4.49 and 4.59 ppm.
FTIR: 3345 (br), 3063, 3028 (w), 2934, 2860 (w), 1736 (s), 1453, 1381, 1386 (w),
1228, 1023 (s), 968, 700 (m) cm-1.
NMR (CDCl3, 300 MHz): δ 7.33 (s, 2H), 7.42 – 7.19 (m, 2H), 5.82 – 5.63 (m,
1H), 5.67 – 5.46 (m, 1H), 4.67 (s, 1H), 4.73 – 4.55 (m, 1H), 4.49 (dt, J = 6.4, 1.0
Hz, 2H), 2.21 – 2.00 (m, 3H), 2.04 (s, 2H), 1.85 (s, 1H), 2.00 – 1.22 (m, 4H) ppm.
1H

NMR (CDCl3, 75 MHz): δ 170.85, 144.69, 135.95, 134.92, 128.46, 127.57,
125.84, 124.18, 123.66, 74.45, 74.38, 65.17, 60.27, 38.44, 32.05, 27.26, 25.53,
25.01, 21.01, 5.79 ppm.
13C

90

Preparation of undeca-1,10-dien-6-ol

Notebook Reference: RDLB178
An oven dried 100 mL 2-neck round bottom flask with stir bar was charged
with magnesium turnings (1.5191g, 62.50 mmol) and fitted with a reflux condenser
and placed under argon. THF (20 mL) was added via syringe followed by
dibromoethane (4 drops) and allowed to stir for 10 mins in order to activate the
magnesium. 5-bromo-1-pentene (6.51 mL, 55.0 mmol) was diluted in 10 mL and
added drop wise over 15 minutes. The reaction was then heated at reflux for 1
hour. The reaction was cooled to room temperature and ethyl formate (2.02 mL,
25 mmol) was added via syringe and the reaction was heated at reflux for 2 hours.
The reaction was cooled to room temperature, poured over 10% HCl (100 mL),
extracted with ether (3 × 50 mL), dried over magnesium sulfate, and concentrated
in vacuo. The resultant crude oil was purified via flash chromatography (6:1
Hex:EtOAc, Rf = 0.34) to afford a clear, colorless oil (3.5806 g, 21.278 mmol, 85%).
FTIR (ATR): 3330 (br), 3076, 2977 (w), 2930, 2859 (m), 1641, 1458, 1440, 1415
(m), 1324 (w), 933, 907, 826 (s) cm-1.
NMR (500 MHz, CDCl3): δ 5.84 (ddt, J = 17.0, 10.2, 6.7 Hz, 2H), 5.08 – 4.95
(m, 4H), 3.64 (q, J = 6.5, 5.1 Hz, 1H), 2.18 – 2.03 (m, 4H), 1.71 – 1.38 (m, 9H),
1.35 – 1.25 (m, 1H) ppm.
1H

13C

NMR (125 MHz, CDCl3): δ 138.7, 114.6, 71.6, 36.9, 33.7, 24.9 ppm.
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Preparation of (2E,11E)-7-hydroxytrideca-2,11-diene-1,13-diyl diacetate

Notebook Reference: RDLA198
An oven dried 100 mL round bottom flask with a stir bar was charged with
p-benzoquinone (104.3 mg, 0.9652 mmol) and Grubbs 2nd Generation Catalyst
(273.1 mg, 0.3217 mmol) and placed under argon. DCM (30 mL) was added via
syringe followed by (Z)-but-2-ene-1,4-diacetoxy (20.52 mL, 128.7 mmol) and
undeca-1,10-dien-6-ol (2.707 g, 16.09 mmol). The reaction was stirred at room
temperature for 3 days. The reaction mixture was concentrated in vacuo, and
purified via flash chromatography (2:1 Hex:EtOAc, Rf = 0.21) to afford a colorless
oil (2.328 g, 13.834 mmol, 86%). E:Z ratio determined to be 6:1 by comparison of
1H

NMR chemical shifts at 4.49 and 4.59 ppm.

FTIR (ATR): 3459 (br), 2933 (w), 1736 (s), 1442, 1363 (w), 1226, 1023 (s), 965
(m) cm-1.
NMR (500 MHz, CDCl3): δ 5.78 (dtt, J = 15.7, 6.7, 1.2 Hz, 2H), 5.69 – 5.52 (m,
2H), 4.56 – 4.49 (m, 4H), 3.61 (s, 1H), 2.23 – 2.03 (m, 10H), 1.63 – 1.47 (m, 4H),
1.50 – 1.37 (m, 4H) ppm.
1H

NMR (125 MHz, CDCl3): δ 170.8, 136.1, 124.1, 71.4, 65.1, 36.9, 32.2, 24.9
ppm.
13C
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Preparation of (2E,11E)-trideca-2,11-diene-1,7,13-triol

Notebook Reference: RDLA255
Potassium hydroxide (392.8, 7.000 mmol) was charged in a 25 mL round
bottom flask with a stir bar and absolute ethanol was added. Deionized water (2
mL) was added until the potassium hydroxide became soluble. (2E,11E)-7hydroxytrideca-2,11-diene-1,13-diyl diacetate (624.8 mg, 2.000 mmol) was diluted
in 1 mL ethanol and added to the solution. The solution was allowed to stir for 1h
and monitored for consumption of starting material by TLC. After 1h, when all the
starting material had been consumed the reaction mixture was poured over a
saturated sodium chloride solution (50 mL), extracted with ethyl actate (3 × 30 mL),
dried over MgSO4, and concentrated in vacuo. The crude product was purified via
column chromatography (0-5% EtOH/EtOAc) to afford a white solid (450.4 mg,
1.972 mmol, 99%)
FTIR (ATR): 3301 (br), 2927 (m), 2856 (m), 1437 (w), 1175, 1084 (m`), 966, 910
cm-1.
(500 MHz, CDCl3): δ 5.74 – 5.63 (m, 4H), 4.09 (dd, J = 5.1, 2.7 Hz, 4H),
3.60 (s, 1H), 2.20 – 2.01 (m, 4H), 1.79-1.12 (m, 8H).
1HNMR

13CNMR

(125 MHz, CDCl3): δ 132.9, 129.4, 71.6, 63.7, 36.8, 32.1, 25.1 ppm.
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Preparation of (2E,11E)-1,13-bis(2,6-dimethyl-4-nitrophenoxy)trideca-2,11dien-7-ol

Notebook Reference: RDLA258
An oven dried 50 mL flask with a stir bar was charged with
triphenylphosphine (725.1 mg, 2.765 mmol) and 2,6-dimethyl-4-nitrophenol (483.3
mg, 2.891 mmol), and placed under argon. Dry THF (10 mL) was added to the
flask via syringe followed by 4-29 (287 mg, 1.25 mmol). The reaction flask was
cooled to -78° C (dry ice/acetone bath). DIAD (0.57 mL, 2.9 mmol) was diluted with
dry THF (10 mL) and added dropwise over 15 minutes. The reaction was stirred
for 48 h. The reaction mixture was diluted with ether, washed with 10% NaOH
solution (3 × 30 mL) and dried over anhydrous magnesium sulfate. The mixture
was gravity filtered, and concentrated in vacuo. The crude product was purified via
column chromatography (2:1 Hex:EtOAc) to give a pale, yellow solid (402.3 mg,
1.159 mmol, 67 %).
FTIR (ATR):
NMR (500 MHz, CDCl3): δ 7.91 (dh, J = 1.3, 0.6 Hz, 2H), 5.90 – 5.66 (m, 2H),
5.08 – 4.88 (m, 6H), 4.32 (d, J = 5.3 Hz, 2H), 3.60 (s, 1H), 2.43 – 2.26 (m, 7H),
2.21 – 2.02 (m, 3H), 1.53 – 1.10 (m, 4H), 1.26 (s, 2H) ppm
1H

13C

NMR (125 MHz, CDCl3): δ
94

Gold-Catalyzed Cyclization of (E)-6-cyclohexylhex-2-ene-1,6-diol

Notebook Reference: RDLA241
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (31.6
mg, 0.150 mmol). AuCl3 (12.4 mg, 0.0500 mmol) was added by scoring the tip of
a 50 μL micropipette loading the solid in the tip and breaking the tip into the reaction
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture
was allowed to stir for 1 h, after which (E)-1-cyclohexyl-6-(2,6-dimethyl-4nitrophenoxy)hex-4-en-1-ol

(142

mg,

0.500

mmol)

was

diluted

in

deuterochloroform (1 mL) and added via syringe. The reaction progress was
monitored by NMR, after 24 h presence of products and absence of starting
material indicated the reaction had ended with nearly complete conversion. The
reaction mixture was filtered through a short plug of silica gel, and concentrated in
vacuo. The crude product was purified via column chromatography (30:1
Hex:EtOAc, Rf = 0.29). Fractions containing the major product were collected and
concentrated in vacuo to afford a clear, colorless oil (36.2 mg, 0.047 mmol, 40%).
Fractions containing the minor product were collected and concentrated in vacuo
to yield a clear, colorless oil (10.1 mg, 11 %).
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Transient 1D-NOESY was performed with selective excitations of the
protons at 3.78 ppm and 3.06 ppm. Diaxial interactions were observed indicating
the constituent of the major product is the cis-isomer.
Based on the yields of the diastereomers the diastereotopic ratio was determined
to be 4:1.
FTIR (ATR): 2922 (s), 2851 (s), 1646, 1450, 1409, 1360 (w), 1203, 1075, 1013 (s),
987, 917, 888 (s) cm-1.
(500 MHz, CDCl3, Major Product): δ 5.87 (ddd, J = 17.4, 10.7, 5.2, 1H),
5.23 (ddd, J = 17.3, 1.7, 1.7, 1H), 5.06 (ddd, , J = 10.7, 1.7, 1.7, 1H), 3.78 (ddddd, ,
J = 11.2, 5.2, 1.6, 1.6, 1.6, 1H), 3.06 (ddd, J = 11.2, 6.8, 2.1,1H), 1.96 (m, 1H),
1.87 (dddd, J = 13.4, 6.7, 3.9, 2.6, 1H), 1.75-0.81 (m, 13H) ppm.
1HNMR

(125MHz, CDCl3, Major Product): δ 139.9, 113.9, 82.1, 43.2, 31.7, 29.3,
28.7, 27.1 ppm.
13CNMR

(500 MHz, CDCl3, Minor Product): δ 5.88 (dddd, J = 17.5, 10.9, 4.3, 0.8,
1H), 5.18 (m, 1H), 4.33 (dddd, , J = 6.2, 4.1, 4.9, 1.9, 1H), 3.35 (ddd, J = 11.0, 8.3,
3.1, 1H), 1.92 (m, 1H), 1.73 (m, 3H), 1.66-1.53 (m, 7H), 1.44 (dddd, J = 18.4, 11.5,
3.9, 1H), 1.36 (dddd, J = 13.4, 9.9, 9.9, 4.2, 1H), 1.29-1.07 (m, 6H), 0.98-0.82 (m,
4H) ppm.
1HNMR

(125MHz, CDCl3, Minor Product): δ 139.1, 115.6, 75.4, 72.3, 41.0, 29.1,
29.7, 28.9, 27.6, 26.7, 26.2, 26.1, 18.9 ppm.
13CNMR
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Gold-Catalyzed Cyclization of (E)-8,8-dimethylnon-2-ene-1,7-diol

Notebook Reference: RDLA251
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (38.5
mg, 0.150 mmol). AuCl3 (15.2, 0.0500 mmol) was added by scoring the tip of a 50
μL micropipette loading the solid in the tip and breaking the tip into the reaction
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture
was allowed to stir for 1 h, after which (E)-8,8-dimethylnon-2-ene-1,7-diol (0.500
mmol) was diluted in deuterochloroform (1 mL) and added via syringe. The
reaction progress was monitored by NMR, after 24 h presence of products and
absence of starting material indicated the reaction had ended with nearly complete
conversion. The reaction mixture was filtered through a short plug of silica gel, and
concentrated in vacuo. The crude product was purified via column chromatography
(19:1 Hex:EtOAc, Rf = 0.41). Fractions containing the pure product were collected
and concentrated in vacuo to afford a clear, colorless oil (78.6 mg, 0.4671 mmol,
93 %).
Transient 1D-NOESY was performed with selective excitations of the
protons at 3.78 ppm and 2.95 ppm. Diaxial interactions were observed indicating
the constituent of the major product is the cis-isomer.
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FTIR (ATR): 2956, 2920 (s), 2870 (m), 1521, 1458, 1341 (m), 1263, 1208, 1150,
1097 (s), 1026, 969 (s) cm-1.
(500 MHz, CDCl3): δ 5.86 (ddd, J = 17.3, 10.7, 4.6 Hz, 1H), 5.24 (dt, J =
17.3, 1.9 Hz, 1H), 5.03 (ddd, J = 10.7, 2.0, 1.6 Hz, 1H), 3.78 (dtd, J = 11.4, 4.0, 1.9
Hz, 1H), 2.95 (dd, J = 11.3, 1.9 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.65 – 1.42 (m, 4H),
1.29 – 1.13 (m, 2H), 0.90 (s, 9H) ppm.
1HNMR

13CNMR

(125MHz, CDCl3): δ 140.2, 113.1, 85.3, 77.9, 34.2, 31.7, 26.1, 25.1, 24.0

ppm.
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Gold-Catalyzed Cyclization of (E)-8,8-dimethylnon-2-ene-1,7-diol

Notebook Reference: RDLB172
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (1.9
mg, 0.0075 mmol). AuCl3 (0.8 mg, .00025 mmol) was added by scoring the tip of
a 50 μL micropipette loading the solid in the tip and breaking the tip into the reaction
tube. MS 4 Å (6 mg). DCM (1 mL) was added via syringe. The mixture was allowed
to mix for 1 h, after which 4-21a (51.6 mg, 0.250 mmol) added via syringe. Reaction
progress monitored by GC. The reaction mixture was filtered through a short plug
of silica gel, and concentrated in vacuo. The crude product was purified via column
chromatography (19:1 Hex:EtOAc, Rf = 0.41). Fractions containing the pure
product were collected and concentrated in vacuo to afford a clear, colorless oil.
Diastereomeric ratio determined to be 4:1 by GC using biphenyl as an internal
reference.
FTIR (ATR): 3024, 2956, 2920 (w) cm-1.
NMR (CDCl3, 300 MHz): δ 7.37 (tdd, J = 7.3, 6.6, 2.8, 1.4 Hz, 2H), 7.37 – 7.18
(m, 2H), 6.07 – 5.86 (m, 1H), 5.38 – 5.20 (m, 1H), 5.11 (dt, J = 10.6, 1.5 Hz, 1H),
4.44 (dd, J = 11.2, 2.2 Hz, 1H), 4.10 – 3.97 (m, 1H), 2.21 – 2.14 (m, 1H), 1.97
(dtd, J = 12.9, 4.7, 4.1, 2.3 Hz, 1H), 1.91 – 1.78 (m, 1H), 1.84 – 1.63 (m, 2H),
1.62 – 1.36 (m, 2H), 1.27 (d, J = 3.6 Hz, 1H), 1.02 – 0.80 (m, 1H) ppm.
1H

NMR (CDCl3, 300 MHz): δ143.3, 139.4, 128.2, 127.2, 125.8, 114.4, 79.7,
78.6, 33.6, 31.3, 24.5, 22.6 ppm.
13C
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Gold-Catalyzed

Cyclization

of

(E)-1-cyclohexyl-7-(2,6-dimethyl-4-

nitrophenoxy)hept-5-en-1-ol

Notebook Reference: RDLA240
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (31.6
mg, 0.123 mmol). AuCl3 (12.4 mg, 0.041 mmol) was added by scoring the tip of a
50 μL micropipette loading the solid in the tip and breaking the tip into the reaction
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture
was allowed to stir for 1 h, after which (E)-1-cyclohexyl-6-(2,6-dimethyl-4nitrophenoxy)hex-4-en-1-ol

(142

mg,

0.410

mmol)

was

diluted

in

deuterochloroform (1 mL) and added via syringe. The reaction progress was
monitored by NMR, and after 24 h presence of products and absence of starting
material indicated the reaction had proceeded with nearly complete conversion.
The reaction mixture was filtered through a short plug of silica gel, and
concentrated in vacuo. The crude product was purified via column chromatography
(19:1 Hex:EtOAc, Rf = 0.39). Fractions containing the pure product were collected
and concentrated in vacuo to afford a clear, colorless oil (9.1 mg, 0.050 mmol,
12 %). Fractions containing the major product and inseparable minor product were
collected and concentrated in vacuo to yield a clear, colorless oil mixture of two
diastereomers (60.2 mg, 0.334 mmol, 81%, dr 6:1). Fraction 1 was determined to
100

be the cis diastereomer by dipolar interactions present in 1D-NOESY with selective
excitations at 3.78 ppm and 3.06 ppm. GC-MS analysis in combination with
isolated yields determined the total diasteremeric ratio to be 7:1. (Calculated yield
of products from collection of data is 69.3 g, 0.357 mmol, 93 %)
FTIR (ATR): 2922 (s), 2851 (s), 1646, 1450, 1409, 1360 (w), 1203, 1075, 1013 (s),
987, 917, 888 (s) cm-1.
(500 MHz, CDCl3, Major Product): δ 5.87 (ddd, J = 17.3, 10.6, 5.1 Hz, 0H),
5.23 (dt, J = 17.3, 1.7 Hz, 0H), 5.06 (dt, J = 10.6, 1.6 Hz, 0H), 3.78 (ddt, J = 13.1,
5.3, 1.8 Hz, 1H), 3.06 (ddd, J = 11.2, 6.7, 2.0 Hz, 1H), 1.96 (dtq, J = 11.9, 3.6, 1.8
Hz, 1H), 1.95 – 1.82 (m, 1H), 1.76 – 1.68 (m, 1H), 1.72 – 1.61 (m, 1H), 1.62 (ddd,
J = 5.0, 3.8, 2.2 Hz, 1H), 1.61 – 1.44 (m, 1H), 1.47 – 1.33 (m, 1H), 1.34 – 1.15 (m,
3H), 1.19 – 1.09 (m, 1H), 1.05 – 0.91 (m, 1H), 0.94 – 0.79 (m, 1H) ppm.
1HNMR

(125MHz, CDCl3, Major Product): δ 139.9, 113.9, 82.1, 43.2, 31.7, 29.3,
28.7, 27.ppm.
13CNMR

101

Gold-Catalyzed

Cyclization

of

(E)-9-(2,6-dimethyl-4-nitrophenoxy)-2,2-

dimethylnon-7-en-3-ol

Notebook Reference: RDLA250
A flame dried 10 mL culture tube with stir bar was charged with AgOTf
(0.150 mmol). AuCl3 (.0500 mmol) was added by scoring the tip of a 50 μL
micropipette loading the solid in the tip and breaking the tip into the reaction tube.
Basic alumina (0.150 mmol) was added to reaction tube to adsorb water and any
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture
was allowed to stir for 1 h, after which (E)-9-(2,6-dimethyl-4-nitrophenoxy)-2,2dimethylnon-7-en-3-ol (0.500 mmol) was diluted in deuterochloroform (1 mL) and
added via syringe. The reaction progress was monitored by NMR, after 24 h
presence of diastereotopic products and absence of starting material indicated the
reaction had ended with nearly complete conversion. The reaction mixture was
filtered through a short plug of silica gel, and concentrated in vacuo. The crude
product was purified via column chromatography (19:1 Hex:EtOAc, R f = 0.40).
Fractions containing the pure product were collected and concentrated in vacuo to
afford a clear, colorless oil (19.3 mg, .1147 mmol, 23%). Fractions containing the
major product and inseparable minor product were collected and concentrated in
vacuo to yield a clear, colorless oil mixture of two compounds (53.7 mg). Fraction
1 was determined to be the cis diastereomer by diaxial interactions present in 1D102

NOESY with selective excitations at 3.78 ppm and 2.95 ppm. GC-MS analysis in
combination with isolated yields determined the total diastereomeric ratio to be
99:1. (Calculated yield of products from collection of data is 73.0 g, 0.434 mmol,
87 %).
FTIR (ATR): 2956, 2920 (s, CvinylH stretch), 2870 (m, CalkylH stretch), 1521, 1458,
1341 (m, CalkylH bend), 1263, 1208, 11250, 1097 (s, CO stretch), 1026, 969 (s,
CvinylH oop bend) cm-1.
1HNMR (500 MHz, CDCl ): δ 5.86 (ddd, J = 17.3, 10.7, 4.6 Hz, 1H), 5.24 (dt, J =
3
17.3, 1.9 Hz, 1H), 5.03 (ddd, J = 10.7, 2.0, 1.6 Hz, 1H), 3.78 (dtd, J = 11.4, 4.0, 1.9
Hz, 1H), 2.95 (dd, J = 11.3, 1.9 Hz, 1H), 1.92 – 1.83 (m, 1H), 1.65 – 1.42 (m, 4H),
1.29 – 1.13 (m, 2H), 0.90 (s, 9H) ppm. ppm.
13CNMR (125MHz, CDCl ): δ 140.2, 113.1, 85.3, 77.9, 34.2, 31.7, 26.1, 25.1, 24.0
3
ppm.
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Gold-Catalyzed Cyclization of (2E,11E)-7-hydroxytrideca-2,11-diene-1,13diyl diacetate

Notebook Reference: RDLA160
A flame dried 10 mL culture tube with stir bar was charged with AuCl3 (11.6
mg, 0.250 mmol) and AgOTf (19.3 mg, 0.0750 mmol) and placed under argon.
Deuterochloroform (2 mL) was added via syringe. The mixture was allowed to stir
for 1 h, after which (2E,11E)-7-hydroxytrideca-2,11-diene-1,13-diyl diacetate
(156.1 mg, 0.500 mmol) was diluted in deuterochloroform (1 mL) and added via
syringe. The reaction progress was monitored by NMR, and after 24 h presence
of products and absence of starting material indicated the reaction had completed
with nearly complete conversion. The reaction mixture was filtered through a short
plug of silica gel, and concentrated in vacuo. The crude product was purified via
column chromatography (12:1 Hex:EtOAc, Rf = 0.70) to afford a clear, colorless oil
(0.0966 g, 0.406 mmol, 81%). The diastereomeric ratio was determined by NMR
using the ratio of 2 and 6 proton chemical shifts of the major (3.32 and 3.80 ppm)
and minor diastereomers (3.67 and 4.33 ppm) to determine a diastereomeric ratio
of 7:1. The confirmation of these diastereomers was determined by 1D-NOESY
with selective excitation of the chemical shifts 3.82 and 3.80 ppm.
FTIR (ATR): 2934 (m), 2859 (m), 1739 (s), 1440 (w), 1363 (w), 1127 (s), 1076 (s),
1023 (s), 966, 917 cm-1.
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(500 MHz, CDCl3): δ 5.93 – 5.81 (m, 1H), 5.77 (dtt, J = 15.7, 6.7, 1.2 Hz,
1H), 5.56 (dtt, J = 15.4, 6.5, 1.5 Hz, 1H), 5.27 – 5.16 (m, 1H), 5.07 (dt, J = 10.6,
1.6 Hz, 1H), 4.50 (dp, J = 6.5, 1.1 Hz, 2H), 3.85 – 3.76 (m, 1H), 3.32 (dddd, J =
11.0, 7.0, 5.0, 1.9 Hz, 1H), 2.16 – 2.02 (m, 2H), 2.06 (s, 3H), 1.85 (dtt, J = 13.4,
5.4, 2.0 Hz, 1H), 1.71 – 1.36 (m, 6H), 1.37 – 1.12 (m, 2H)) ppm.
1HNMR

(125MHz, CDCl3): δ 170.9, 139.7, 136.4, 123.9, 114.3, 78.2, 76.8, 65.3,
36.0, 32.3, 31.5, 31.3, 24.9, 23.6 ppm.
13CNMR
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Gold-Catalyzed Cyclization of (2E,11E)-trideca-2,11-diene-1,7,13-triol

Notebook Reference: RDLA256
A flame dried 10 mL culture tube with stir bar was charged with AgOTf (38.5
mg, 0.150 mmol). AuCl3 (15.2 mg, 0.0500 mmol) was added by scoring the tip of
a 50 μL micropipette loading the solid in the tip and breaking the tip into the reaction
tube. Basic alumina (10 mg) was added to reaction tube to adsorb water and any
HCL in solution. Deuterochloroform (2 mL) was added via syringe. The mixture
was allowed to stir for 1 h, after which (2E,11E)-trideca-2,11-diene-1,7,13-triol
(0.500 mmol) was diluted in deuterochloroform (1 mL) and added via syringe. The
reaction progress was monitored by NMR, and after 24 h presence of products
and absence of starting material indicated the reaction had completed with nearly
complete conversion. The reaction mixture was filtered through a short plug of
silica gel, and concentrated in vacuo. The crude product was purified via column
chromatography (15:1 Hex:EtOAc, Rf =0.32) to afford a clear, colorless oil (99 mg,
94%). The diastereomeric ratio was determined by NMR using the ratio of 2 and 6
proton chemical shifts of the major (3.32 and 3.80 ppm) and minor diastereomers
(3.67 and 4.33 ppm) to determine a diastereomeric ratio of 4:1. The relative
confirmation of these diastereomers was determined by 1D-NOESY with selective
excitation of the chemical shifts 3.82 and 3.80 ppm.
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FTIR (ATR): 2934 (m, CvinylH stretch), 2859 (m, CalkylH stretch), 1739 (s, ester
carbonyl CO stretch), 1440 (w, CvinylH oop bend), 1363 (w, CvinylH stretch), 1127
(s, CO stretch), 1076 (s, CO stretch), 1023 (s, CO stretch), 966, 917 cm -1.
(500 MHz, CDCl3): δ 5.98 – 5.78 (m, 0H), 5.32 – 5.15 (m, 1H), 5.14 – 5.00
(m, 1H), 3.77 (ddq, J = 11.1, 5.4, 2.0 Hz, 1H), 3.06 (ddd, J = 11.2, 6.7, 2.0 Hz, 1H),
2.01 – 1.79 (m, 2H), 1.71 (s, 3H), 1.70 – 1.49 (m, 5H), 1.54 – 1.33 (m, 1H), 1.39 –
1.20 (m, 1H), 1.25 (s, 1H), 1.25 – 1.11 (m, 2H), 0.98 (dtdd, J = 31.2, 15.8, 11.4,
7.1 Hz, 3H) ppm.
1HNMR

(125MHz, CDCl3): δ 170.9, 139.7, 136.4, 123.9, 114.3, 78.2, 76.8, 65.3,
36.0, 32.3, 31.5, 31.3, 24.9, 23.6 ppm.
13CNMR
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Gold-Catalyzed

Cyclization

of

(2E,11E)-1,13-bis(2,6-dimethyl-4-

nitrophenoxy)trideca-2,11-dien-7-ol

Notebook Reference: RDLA264
A flame dried 10 mL culture tube with stir bar was charged with AgOTf
(38.5mg, 0.1500 mmol) and basic alumina (10 mg). AuCl3 (15.2 mg, 0.0500 mmol)
was massed into the tip of a scored micropipette, broken off into the tube and
placed under argon. Deuterochloroform (1 mL) was added via syringe. The mixture
was allowed to stir for 1 h, after which (2E,11E)-1,13-bis(2,6-dimethyl-4nitrophenoxy)trideca-2,11-dien-7-ol (263.3 mg, 0.500 mmol) was diluted in
deuterochloroform (1 mL) and added via syringe. The reaction progress was
monitored by NMR, and after 24 h presence of products and absence of starting
material indicated the reaction had completed with nearly complete conversion.
The reaction mixture was filtered through a short plug of silica gel, and
concentrated in vacuo. The crude product was purified via column chromatography
(15:1 Hex:EtOAc, Rf = 0.28) to afford a clear, slight yellow oil (21.6 mg, 12%) as a
single diastereomer.
FTIR (ATR): 2956, 2920 (s), 2870 (m), 1521, 1458, 1341 (m), 1263, 1208, 11250,
1097 (s), 1026, 969 (s) cm-1.
(500 MHz, CDCl3): δ 7.91 (s, 1H), 5.95 – 5.64 (m, 1H), 5.29 – 5.14 (m,
0H), 5.13 – 5.00 (m, 0H), 4.31 (t, J = 4.9 Hz, 1H), 3.86 – 3.74 (m, 1H), 3.39 – 3.25
1HNMR
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(m, 1H), 2.41 – 2.27 (m, 3H), 2.10 (q, J = 6.5 Hz, 1H), 1.84 (dq, J = 9.9, 3.9, 3.0
Hz, 1H), 1.57 (s, 3H), 1.51 (s, 1H), 1.76 – 1.12 (m, 2H), 0.85 (s, 3H) ppm.
(125MHz, CDCl3): δ 139.6, 136.4, 132.6, 124.8, 124.1, 114.3, 78.2, 77.5,
73.5, 36.0, 34.0, 32.3, 31.4, 31.3, 29.7, 27.7, 24.9, 23.5, 16.8 ppm.
13CNMR
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Catalyst Loading and Control Experiments in the Gold-Catalyzed Cyclization
to Form 2-phenyl-6-vinyltetrahydro-2H-pyran

Notebook Reference: RDLB172
To a 2 mL vial was charged catalyst at the specified loading, internal
reference biphenyl (19.3 mg, 0.125 mmol) and additive MS 4 Å (if specified, 20 %
w/w). Anhydrous DCM (1 mL) was added via syringe and the catalyst was allowed
to from over 30 minutes at room temperature. Substrate 4-21a (51.6 mg, 0.250
mmol) was massed into a syringe and added to the reaction vessel by mixing
solution four times by mixing within the syringe. Every 10 minutes for 40 minutes
an aliquot (25 L) was removed from the reaction solution and passed through a
short plug of silica and rinsed with DCM directly into a GC sample vial. Using the
same procedure aliquots were taken at 4 hours and 24 hours. Samples were
analyzed by GC-MS against known sample retention factors. See Table 4-2 for
results.
FTIR (ATR): 3024, 2956, 2920 (w) cm-1.
NMR (CDCl3, 300 MHz): δ 7.37 (tdd, J = 7.3, 6.6, 2.8, 1.4 Hz, 2H), 7.37 – 7.18
(m, 2H), 6.07 – 5.86 (m, 1H), 5.38 – 5.20 (m, 1H), 5.11 (dt, J = 10.6, 1.5 Hz, 1H),
4.44 (dd, J = 11.2, 2.2 Hz, 1H), 4.10 – 3.97 (m, 1H), 2.21 – 2.14 (m, 1H), 1.97
(dtd, J = 12.9, 4.7, 4.1, 2.3 Hz, 1H), 1.91 – 1.78 (m, 1H), 1.84 – 1.63 (m, 2H),
1.62 – 1.36 (m, 2H), 1.27 (d, J = 3.6 Hz, 1H), 1.02 – 0.80 (m, 1H) ppm.
1H

NMR (CDCl3, 300 MHz): δ143.3, 139.4, 128.2, 127.2, 125.8, 114.4, 79.7,
78.6, 33.6, 31.3, 24.5, 22.6 ppm.
13C
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Analysis of Solvent Effects in the Gold-Catalyzed Cyclization to Form 2phenyl-6-vinyltetrahydro-2H-pyran

Notebook Reference: RDLB178
To a 2 mL vial were charged biphenyl (19.3mg, 0.125 mmol), AuCl3 (0.4 mg,
0.00125 mmol), and AgOTf (1.0 mg, 0.00375 mmol). Solvent (0.5 mL) was added
via syringe and catalyst was allowed to form over 30 minutes at room temperature.
Substrate 4-24 (31.0 mg, 0.125 mmol) was massed into a syringe and added to
the reaction by mixing the syringe 4 times. Every 10 minutes for 40 minutes an
aliquot (20 L) was removed, filtered through a plug of silica and rinsed with DCM
directly into a GC sample vial. A final aliquot was obtained using the same method
after 12 hours. Samples were analyzed by GC-MS against known sample retention
factors. See Table 4-3 for results.
FTIR (ATR): 3024, 2956, 2920 (w) cm-1.
NMR (CDCl3, 300 MHz): δ 7.37 (tdd, J = 7.3, 6.6, 2.8, 1.4 Hz, 2H), 7.37 – 7.18
(m, 2H), 6.07 – 5.86 (m, 1H), 5.38 – 5.20 (m, 1H), 5.11 (dt, J = 10.6, 1.5 Hz, 1H),
4.44 (dd, J = 11.2, 2.2 Hz, 1H), 4.10 – 3.97 (m, 1H), 2.21 – 2.14 (m, 1H), 1.97
(dtd, J = 12.9, 4.7, 4.1, 2.3 Hz, 1H), 1.91 – 1.78 (m, 1H), 1.84 – 1.63 (m, 2H),
1.62 – 1.36 (m, 2H), 1.27 (d, J = 3.6 Hz, 1H), 1.02 – 0.80 (m, 1H) ppm.
1H

NMR (CDCl3, 300 MHz): δ143.3, 139.4, 128.2, 127.2, 125.8, 114.4, 79.7,
78.6, 33.6, 31.3, 24.5, 22.6 ppm.
13C
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Preparation of 5-hydroxy-N-methoxy-N-methylpentanamide

Notebook Reference: RDLB068
To a suspension of 𝛿-valerolactone (0.65 mL, 6.955 mmol) and N,O dimethylhydroxyamine hydrochloride (1.695g, 17.38 mmol) in 50 mL THF at -20 °C
was added dropwise over a period of 30 minutes a solution of iPrMgCl (25 mL,
38.25 mmol). The mixture was stirred at -20 °C for 2 hours, then quenched with 25
mL of saturated NH4Cl solution. The layers were separated and the aqueous layer
was extracted three times with EtOAc. The combined organic layers were washed
with brine, dried with anhydrous MgSO4 and concentrated in vacuo. The crude
product was purified by filtration through plug of silica with EtOAc to yield the 5hydroxy-N-methoxy-N-methylpentanamide as colorless oil (472.9 mg, 42%, Rf =
0.3 in EtOAc) that satisfactorily matched previously previously reported data.
FTIR (ATR): 3405 (br), 2938, 2870 (m), 1637 (s), 1417 (m), 1386, 1324 (m), 1179
(s) cm-1
NMR (500 MHz, CDCl3)  3.7 – 3.6 (m, 3H), 3.2 (s, 2H), 2.5 (t, J = 7.2 Hz, 1H),
1.7 (dtd, J = 8.2, 7.4, 6.6 Hz, 1H), 1.7 – 1.6 (m, 2H) ppm.
1H

13C

NMR (125 MHz, CDCl3)  183.3, 62.1, 61.2, 32.1, 30.9, 19.9 ppm.

112

Preparation

of

5-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-

methylpentanamide

Notebook Reference: RDLB070
To a solution of the alcohol (459.9 mg, 2.853 mmol) in 30 mL of DCM at
0 °C was added imidazole (427.3 mg, 6.277mmol) followed by TBSCl (473.0 mg,
3.138 mmol). The mixture was allowed to warm to room temperature and stirred
overnight. The reaction was quenched with 10 mL H2O. The layers were separated
and the aqueous layer was extracted three times with DCM. The combined organic
layers were washed with 1N HCl (15mL), saturated NaHCO3 (15 mL) and finally
with brine (15 mL), dried with anhydrous MgSO4 and concentrated in vacuo. The
crude product was purified by flash chromatography (hexanes to 15% EtOAc in
hexanes) to yield 2.07g of (93%) of colorless oil that satisfactory matched all
previously reported data.
FTIR (ATR): 3035, 2923, 2854 (w), 1586 (w), 1576, 1485,1466, 1456 (s) cm-1.
NMR (300 MHz, CDCl3) 3.70 – 3.52 (m, 5H), 3.13 (s, 3H), 3.12 (s, 2H), 2.40 (t,
J = 7.4, 2H), 1.73 – 1.43 (m, 4H), 0.90 (s, 9H), 0.00 (s, 6H) ppm.
1H

13C

NMR (75 MHz, CDCl3) 62.8, 61.1, 32.4, 25.9, 21.1, 18.3, -5.4 ppm
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Preparation of 1-((tert-butyldimethylsilyl)oxy)dec-9-en-5-one

Notebook Reference: RDLB080
To an oven dried 50 mL reaction tube with stir bar was charged magnesium
shavings (160.4 mg, 6.600 mmol), and heated with a heat gun under vacuum (10
Torr) for 10 minutes, then cooled under argon. Anhydrous THF (2 mL) was added
via syringe. At room temperature 5-bromopentene (0.39 mL, 3.3 mmol) in THF (2
mL) was added over the period of 10 minutes. The reaction began to reflux
indicating Grignard reagent formation, and was stirred for 30 mins after refluxing
had subsided. The reaction was added dropwise to a solution of 5-((tertbutyldimethylsilyl)oxy)-N-methoxy-N-methylpentanamide (0.6000 2.200 mmol) in
THF (4 mL) at -78 °C and stirred for 10 mins, then gradually warmed to 0 °C and
stirred for 1h. Reaction quenched with water 10 mL, extracted with EtOAc (3×30
mL), washed with brine (3×30 mL), dried with MgSO4, and concentrated in vacuo.
Purified by column chromatography (9:1 Hex:EtOAc) to yield a colorless oil (0.2166
g, 35%) . Rf = 0.47 in 9:1 Hex:EtOAc.
NMR (300 MHz, CDCl3): δ 5.74 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.06 – 4.85
(m, 2H), 3.59 (t, J = 6.2 Hz, 2H), 2.39 (td, J = 7.3, 4.2 Hz, 4H), 2.11 – 1.95 (m, 2H),
1.74 – 1.40 (m, 6H), 0.87 (s, 9H), 0.02 (s, 6H) ppm
1H

NMR (75 MHz, CDCl3): δ 211.0, 138.0, 115.2, 62.8, 42.6, 41.8, 33.1, 32.27,
25.9, 22.8, 20.3, 18.3, -5.3 ppm
13C
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Preparation of (E)-1-((tert-butyldimethylsilyl)oxy)-11-hydroxyundec-9-en-5one

Notebook Reference: RDLB086
To an oven dried 10 mL tube with stir bar was charged with Grubbs 2 nd
generation catalyst (64.4 mg, 0.0759 mmol) and p-benzoquinone (8.2 mg, 0.0759
mmol), and placed under argon. DCM (1 mL) added via syringe. Z-2-butene-1,4diol (0.37 mL, 4.5 mmol) and alkenone (0.216 g, 0.759 mmol) were mixed and
diluted into DCM (0.5 mL), then added to the reaction vessel. Reaction stirred
overnight at rt. Crude mixture purified through short plug of silica, rinsed with
DCM and concentrated in vacuo. Purified by column chromatography with 2:1
Hex:EtOAc to yield slightly red oil (145 mg, 60%).
FTIR (ATR): 3357 (br), 2928(m), 2856 (m), 1711 (s), 1462 (w), 1361, 1253 (w,
CO stretch), 1095 (m) cm-1.
NMR (300 MHz, CDCl3) δ 5.65 – 5.57 (m, 2H), 4.07 – 4.01 (m, 2H), 3.57 (t, J
= 6.2 Hz, 2H), 2.43 – 2.33 (m, 4H), 2.06 – 1.94 (m, 2H), 1.76 (s, 1H), 1.69 – 1.53
(m, 4H), 1.51 – 1.42 (m, 2H), 0.85 (s, 9H), 0.01 (s, 6H) ppm.
1H

NMR (75 MHz, CDCl3) δ 211.0, 132.0, 129.8, 63.5, 62.8, 42.6, 41.8, 32.2,
31.5, 25.9, 23.0, 20.3, 18.3, -5.4 ppm.
13C
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Preparation of (E)-1-((tert-butyldimethylsilyl)oxy)-11-(2,6-dimethyl-4nitrophenoxy)undec-9-en-5-one

Notebook Reference: RDLB092
To a flame dried 10 mL tube was charged 2,6-dimethyl-4-nitrophenol
(91.9 mg, 0.550 mmol) and triphenylphosphine (133.7 mg, 0.5100 mmol), and
placed under argon. 5-18 (145 mg, 0.460 mmol) in THF (1 mL) added via
syringe. DIAD (0.51 mmol) diluted in THF (1 mL) and added dropwise. Stirred
room temperature for 48 hours. Reaction mixture diluted with EtOAc, washed
with 10% NaOH, washed with brine, dried MgSO4, and concentrated in vacuo.
Purified by column chromatography with 9:1 Hex:EtOAc to yield yellow oil (83.9
mg, 40%). Rf = 0.27 in 9:1 Hex:EtOAc.
NMR (300 MHz, CDCl3): δ 7.90 (s, 2H), 5.75 (m, 2H), 4.31 (d, J = 4.7, 2H),
3.60 (t, J = 6.2 Hz, 2H), 2.40 (m, 2H), 2.33 (s, 6H), 2.08 (m, 2H), 1.74-1.44 (m
6H), 0.88 (s, 9H), 0.03 (s, 6H) ppm.
1H

NMR (75 MHz, CDCl3): δ 210.7, 161.3, 135.4, 132.6, 125.6, 124.2, 73.73,
62.8, 42.8, 41.9, 32.4, 31.6, 26.0, 22.9, 20.4, 18.2, 16.8, -5.2
13C

116

Preparation of (E)-11-(2,6-dimethyl-4-nitrophenoxy)-1-hydroxyundec-9-en-5one

Notebook Reference: RDLB096
To a 10 mL tube was added alkenone (83.9 mg, 0.181 mmol) in THF (1
mL). TBAF (236.5 mg, 0.905 mmol) added and mixture stirred at room
temperature overnight. Water (2 mL) added to the reaction vessel, extracted with
EtOAc, dried over MgSO4 and concentrated in vacuo. Purified by column
chromatography with 1:1 Hex:EtOAc to yield a yellow oil (16.5 mg, 26 %).
NMR (300 MHz, CDCl3):  7.90 (s, 2H), 5.87 – 5.61 (m, 2H), 4.32 (d, J = 4.0
Hz, 2H), 3.58 (m, 2H), 2.16 – 1.95 (m, 4H), 2.09 (s, 3H), 1.80 – 1.58 (m, 2H),
1.50 – 1.28 (m, 1H), 1.25 (s, 1H), 0.97 – 0.78 (m, 1H) ppm.
1H

NMR (75 MHz, CDCl3): δ 210.51, 161.30, 143.40, 135.86, 135.22, 132.52,
132.50, 126.90, 125.54, 125.19, 124.13, 113.29, 98.67, 73.38, 73.27, 61.37,
58.95, 42.71, 41.90, 36.53, 32.96, 32.38, 31.62, 29.57, 25.85, 25.31, 24.94,
22.82, 22.64, 20.92, 18.65, 16.81 ppm.
13C
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Au(III)-Catalyzed Cyclization of (E)-11-(2,6-dimethyl-4-nitrophenoxy)-1hydroxyundec-9-en-5-one

Notebook Reference: RDLB110
To a flame dried 5 mL scintillation vial with stir bar was charged AuCl3
(0.001 mmol), AgOTf (0.003 mmol), and basic alumina (10 mg). The reaction
vessel was placed under argon and 0.2 mL CDCl3 was added via syringe. The
mixture was heated at 60 ˚C for 1 hour to ensure catalyst formation, then cooled
to room temperature. Substrate 5-20 was diluted in 0.3 mL CDCl3 and added via
syringe. Reaction checked by NMR after 24 hours to indicate ~60% conversion of
substrate to hemiketal 5-21. The reaction was then heated at reflux overnight. No
observable formation of spiroketal was observed. Reaction was passed through
a plug of silica, and concentrated in vacuo. The crude mixture was purified by
MPLC (25 mm Column, 5 mL/min, 1:1 Hex EtOAc) to afford hemiketal susbtrate
(5.4 mg, 60 %). Diastereomeric ratio estimated from MPLC chromatogram
approximately (10:1).
(500 MHz, CDCl3): δ 7.92 (s, 2H), 5.75 (m, 2H), 4.33 (d, J = 4.6 Hz, 2H),
3.63 (m, 2H), 2.42 (m, 2H), 2.36 (s, 6H), 2.09 (m, 2H), 1.74-1.49 (m, 6H), 1.26 (s,
1H)
1HNMR
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Preparation of 1-(4-methoxyphenyl)hex-5-en-1-ol

Notebook Reference: RDLB078
To an oven dried 50 mL tube with stir bar was charged magnesium
shavings (1.823 mg, 75.00 mmol) and place under argon. Anhydrous THF (15
mL) was added via syringe. 5-bromopentene (4.44 mL, 37.5 mmol) was added
dropwise via syringe over 15 minutes. Solution generated enough heat to reflux.
This was allowed to stir for 30 minutes. On the side an oven dried 250 mL round
bottom flask with addition funnel and stir bar was assembled hot and placed
under argon to cool. THF (40 mL) was added by syringe followed by panisaldehyde (3.04 mL, 25.00 mmol). The reaction vessel was cooled to -78 ˚C
(dry ice/isopropanol bath). The prepared Grignard reagent 6-11 was added via
cannula to the addition funnel and added dropwise to the solution over 10
minutes. The reaction vessel was warmed to 0 ˚C and stirred for 1 hour, then
room temperature for 1 hour. The reaction was quenched with NH4Cl (40 mL)
added dropwise over 10 minutes. Organics were extracted with EtOAc, washed
with brine, dried over MgSO4, and concentrated in vacuo to afforded the desired
compound with slight aldehyde impurity as determined by NMR. The crude
product was purified by column chromatography (70 mm, 6:1 Hex:EtOAc) to yield
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desired product 6-12 as a clear, colorless oil (4.4081, 21.368 mmol, 85 %). Rf =
0.25 in 6:1 Hex:EtOAc.
FTIR (ATR): 3370 (br), 3085 (w), 2934, 2836 (w), 1640, 1611 (w), 1586, 1511,
1459, 1441 (w), 1302, 1243, 1173 (s), 994, 909 (s), 830 (m) cm-1.
NMR (300 MHz, CDCl3):  7.27 (d, J = 8.9 Hz, 2H), 6.93 – 6.84 (d, J = 8.5 Hz,
2H), 5.78 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.04 – 4.90 (m, 2H), 4.67 – 4.59 (m,
1H), 3.81 (s, 3H), 2.07 (d, J = 6.7 Hz, 1H), 1.89 – 1.62 (m, 3H), 1.50 (dddd, J =
12.6, 10.4, 7.5, 5.2 Hz, 1H), 1.37 (dddd, J = 13.2, 10.8, 7.8, 5.6 Hz, 1H) ppm.
1H

NMR (75 MHz, CDCl3):  159.1, 138.6, 136.9, 127.1, 114.6, 113.8, 74.1,
55.3, 38.4, 33.6, 25.1, 16.2 ppm.
13C
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Preparation of 4-(benzyloxy)benzaldehyde

Notebook Reference: RDLB162
To a 100 mL round bottom flask with stir bar was charged with K2CO3
(6.190 g, 50.00 mmol). Acetone (50 mL) was added followed by phydroxybenzaldehyde (3.053 g, 25.00 mmol) and benzyl bromide (3.00 mL, 27.5
mmol). The reaction was fitted with a condenser, refluxed overnight, and TLC
showed complete consumption of starting material. Reaction concentrated in
vacuo. The crude mixture was diluted with EtOAc, washed with saturated K 2CO,
washed with brine, dried MgSO4 and concentrated in vacuo to yield the product
6-17 as a white solid (4.56 g, 21.5 mmol, 86 %) with no further purification
necessary.
FTIR (ATR): 3057 (w), 2829 (w), 2745 (w), 1686 (s), 1598, 1574, 1509, 1462,
1452 (m), 1321, 1301, 1252, 1213 (m) cm-1.
(500 MHz, CDCl3):  9.89 (s, 1H), 7.88 – 7.81 (m, 2H), 7.47 – 7.30 (m,
5H), 7.26 (s, 1H), 7.12 – 7.05 (m, 2H), 5.16 (s, 2H) ppm.
1HNMR

NMR (75 MHz, CDCl3):  215.2, 190.8, 163.7, 135.9, 132.0, 130.1, 128.7,
128.3, 127.5, 115.1, 70.3, 16.2 ppm.
13C
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Preparation of 1-(4-(benzyloxy)phenyl)prop-2-en-1-ol

Notebook Reference: RDLB176, RDLB104
To oven dried 100 mL 2-neck round bottom flask with stir bar and addition
funnel was charged substrate 6-17 (4.132 g, 19.46 mmol), and placed under
argon. THF (40 mL) was added via syringe, and the reaction vessel was cooled
to -78 ˚C. Vinyl magnesium bromide (1M in THF, 23.35 mL) was added drop wise
over 10 minutes. The reaction was warmed to 0 ˚C and stirred for 1 hour after
which TLC indicated complete conversion of starting material. NH4Cl (40 mL)
was added dropwise, extracted with EtOAc, washed with brine, dried with
MgSO4, and concentrated in vacuo. The crude product was purified by column
chromatography (75 mm, 6:1-3:1 Hex:EtOAc) to yield the desired product 6-18
as a white solid (4.0511 g, 16.86 mmol, 87 - 91 %). Rf = 0.17 in 6:1 Hex:EtOAc.
FTIR (ATR): 3320 (br), 3068, 3031 (w), 2910 (w), 2867 (w), 1611, 1585, 1509,
1470, 1454, 1421, 1376 (m), 1318, 1302, 1244, 1194 (m), 987, 916 (s) cm-1.
(300 MHz, CDCl3):  7.50 – 7.32 (m, 4H), 7.40 – 7.14 (m, 3H), 7.07 –
6.86 (m, 2H), 6.15 – 5.95 (m, 1H), 5.34 (dtd, J = 17.1, 1.4, 0.5 Hz, 1H), 5.28 –
4.94 (m, 2H), 5.07 (s, 2H) ppm.
1HNMR

NMR (75 MHz, CDCl3):  158.42, 140.32, 136.94, 135.09, 128.58, 127.95,
127.69, 127.43, 114.90, 114.79, 74.87, 70.04 ppm.
13C
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Preparation of 1-(4-(benzyloxy)phenyl)allyl acetate

Notebook Reference: RDLB184
To a flame dried 50 mL tube with stir bar was charge substrate 6-18
(1.201 g, 5.00 mmol) and placed under argon. DCM (20 ml) was added via
syringe, and DMAP (1.466 g, 12.00 mmol) was added, followed by acetic
anhydride (0.57 mL, 6.0 mmol). The reaction was refluxed for 1 hour upon which
complete consumption of the starting material was observed. The organics were
washed with 10 % HCl, then NaHC2O3, dried MgSO4, and concentrated in vacuo.
The crude product was purified by column chromatography (40 mm, 12:
Hex:EtOAc) to yield the intended product as a colorless amorphous solid (678.2
mg, 2.402 mmol, 48 %). Rf = 0.32 in 6:1 Hex:EtOAc.
FTIR (ATR): 3035 (w), 2934 (w), 1735 (s), 1645, 1610, 1586, 1513, 1466, 1454,
1418 (m), 1386, 1367, 1300, 1227, 1176 (m), 992, 908 (s) cm-1.
(300 MHz, CDCl3):  7.49 – 7.23 (m, 6H), 7.32 – 7.20 (m, 1H), 7.06 –
6.89 (m, 2H), 6.23 (d, J = 5.7 Hz, 1H), 6.00 (dddd, J = 17.0, 10.4, 5.7, 0.7 Hz,
1H), 5.36 – 5.17 (m, 2H), 5.06 (s, 2H), 2.09 (s, 3H) ppm.
1HNMR

NMR (75 MHz, CDCl3):  170.01, 136.84, 136.33, 131.26, 128.70, 128.58,
127.98, 127.43, 116.49, 114.82, 75.78, 70.02, 21.28 ppm.
13C
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Preparation of (E)-1-(4-(benzyloxy)phenyl)-7-(4-methoxyphenyl)hept-2-ene1,7-diol

Notebook Reference: RDLB186
To an oven dried 2-neck 25 mL round bottom flask with stir bar was
charged Grubbs 2nd generation catalyst (20.4 mg, 0.02402 mmol) and pbenzoquinone (13.0 mg, 0.1201 mmol), and placed under argon. DCM (8 mL)
was added to a mixture of substrate 6-12 (247.8 mg, 1.201 mmol) and 6-19
(678.2 mg, 2.402 mmol) and added to the flask via syringe. The flask was fitted
with a reflux condenser and the reaction was heated with an oil bath at 40 ˚C
overnight. TLC indicated presence of products. The reaction mixture was pass
through a plug of silica and rinsed with EtOAc, and concentrated in vacuo. The
crude product was purified by column chromatography (40 mm, 6:1-3:1
Hex:EtOAc). Two fractions were collected. Starting material 6-12 was collected in
fraction 1 (348.6 mg, 1.945 mmol, 81 % recovery). Starting material 6-19 was
collected in fraction 2 (100.7 mg, 0.4881 mmol, 41 % recovery). Acetone was
rinsed through the column, and concentrated in vacuo. This was crude product
was purified by column chromatography (40 mm, 3:1-2:1 Hex:EtOAc) to yield the
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intended product 6-20 as a viscous oil (65.9 mg, 0.1431 mmol, 62 % reacted
yield, 12 % overall yield).
FTIR (ATR): 3435 (br), 3050 (w), 2855 (w), 1729 (s), 1606, 1509, 1454, 1371,
1301 (w), 1238, 1174, 1018, 967 (s) cm-1.
(300 MHz, CDCl3):  7.46 – 7.19 (m, 9H), 7.01 – 6.83 (m, 4H), 6.56 –
6.48 (m, 1H), 5.95 (ddd, J = 15.9, 7.6, 2.9 Hz, 1H), 5.36 (tt, J = 9.7, 4.8 Hz, 1H),
5.07 (s, 2H), 4.65 – 4.58 (m, 1H), 3.80 (t, J = 2.6 Hz, 3H), 2.04 (s, 3H), 1.84 –
1.71 (m, 1H), 1.34 (dtt, J = 19.3, 9.8, 5.1 Hz, 1H), 1.26 (s, 1H) ppm.
1HNMR

NMR (75 MHz, CDCl3):  170.38, 159.07, 159.00, 158.63, 136.84, 136.79,
136.77, 132.28, 132.19, 130.29, 129.30, 128.57, 127.97, 127.80, 127.41, 127.12,
127.07, 125.47, 125.42, 114.92, 113.85, 113.80, 77.20, 74.85, 74.81, 74.15,
74.02, 74.00, 70.01, 55.27, 38.55, 38.38, 34.42, 32.32, 29.69, 25.73, 21.63,
21.60, 21.36 ppm.
13C
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Au(III)-Catalyzed Cyclization of (E)-1-(4-(benzyloxy)phenyl)-7-(4methoxyphenyl)hept-2-ene-1,7-diol

Notebook Reference: RDLB192
To 5 mL scintillation vial AuCl3 (0.4 mg, 0.001 mmol), AgOTf (1.0 mg,
0.00375 mmol), and MS 4 Å (3.3 mg, 20% w/w). The reaction was placed under
argon and Anhydrous DCM (0.2 mL) was added via syringe. The catalyst was
allowed to form over 30 minutes. Substrate 6-20 (57.4 mg, 0.125 mmol) was
diluted in DCM (0.3 mL) and added via syringe. Reaction changed to purple color
in less than 1 minute, and TLC taken indicated complete consumption of starting
material. Reaction was passed through a plug of silica, rinsed DCM, and
concentrated in vacuo. The crude product was purified by column
chromatography (15:1-9:1 Hex:EtOAc) to yield the desired product 6-21 as a
colorless solid (41.3 mg, 0.103 mmol, 82 %).
FTIR (ATR): 2924 (w), 2854 (w), 1725, 1607, 1511, 1455 (w), 1246, 1174, 1124,
1074 (m) cm-1.
(500 MHz, CDCl3): 7.72 (dq, J = 4.5, 2.4 Hz, 2H), 7.53 (dd, J = 5.9, 3.3
Hz, 2H), 7.46 – 7.37 (m, 2H), 7.42 – 7.28 (m, 3H), 6.96 – 6.84 (m, 4H), 6.57 (dd,
J = 16.0, 1.2 Hz, 1H), 6.17 (dd, J = 16.0, 6.0 Hz, 1H), 5.06 (s, 2H), 4.43 (dd, J =
11.3, 2.1 Hz, 1H), 4.31 (dq, J = 10.6, 7.3 Hz, 2H), 4.22 – 4.13 (m, 1H), 3.80 (s,
2H), 2.00 (dt, J = 10.1, 3.8 Hz, 1H), 1.86 – 1.66 (m, 4H), 1.66 – 1.44 (m, 2H),
1.26 (s, 10H), 1.03 – 0.74 (m, 8H) ppm.
1HNMR

NMR (125 MHz, CDCl3):  167.67, 158.84, 158.25, 136.96, 135.58, 130.88,
130.14, 129.21, 129.00, 128.80, 128.54, 127.92, 127.60, 127.44, 127.27, 114.82,
13C
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113.64, 79.59, 78.83, 70.00, 55.27, 33.37, 31.74, 29.72, 29.69, 24.06, 22.68,
14.11 ppm.
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